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Abstract
Nitric oxide is a biological messenger which is synthesized enzymatically throughout the
body and which has numerous physiological functions, including roles in blood pressure control,
regulation of clotting, and neurotransmission. It is produced also by macrophages as part of the
non-specific immune response, and has been shown to be toxic to invasive microorganisms.
However, sustained overproduction of NO, as observed with chronic inflammation or infection,
may damage the host tissue and has been linked to increased risk for cancer. Nitric oxide may
facilitate tumorigenesis or metastasis by influencing tumor-cell proliferation, angiogenesis, or
lymphangiogenesis. However, the concentrations of NO in inflamed tissues or during
carcinogenesis are largely unknown. The objective of the research in this thesis was to predict
NO concentrations in an inflamed colon and a cutaneous metastatic melanoma, two areas where
NO has been implicated in the development or progression of disease.
Nitric oxide production in the colon has been linked to inflammatory bowel disease
(IBD) and increased risk for colon cancer. However, measurements of NO concentration in the
inflamed colon have not been available and it is not known what levels of NO are
pathophysiological. A computational model, based on anatomical length scales and rates of NO
production measured in cell cultures, was developed to predict spatially varying NO
concentrations within a colonic crypt under inflammatory conditions. A variety of scenarios
were considered, including different spatial distributions of macrophages and a range of possible
macrophage and epithelial synthesis rates for NO. The results were used to predict the range of
NO concentrations (<0.3 tM) and cumulative NO dose (560 [tM * min) experienced by a given
epithelial cell migrating from the base to the top of the crypt. This first set of predictions was
based on literature data on the cellular synthesis and consumption of NO.
Knowledge of the rates at which macrophages and epithelial cells synthesize NO is
critical for predicting the concentrations of NO and other reactive nitrogen species in colonic
crypts during inflammation, and elucidating the linkage between inflammatory bowel disease,
NO, and cancer. Macrophage-like RAW264.7 cells, primary bone marrow-derived macrophages
(BMDM), and HCT116 colonic epithelial cells were subjected to simulated inflammatory
conditions, and rates of formation and consumption were determined for NO, O2, and 02-.
Production rates of NO were determined in either of two ways: continuous monitoring of NO
concentrations in a closed chamber, with corrections for autoxidation; or NO2- accumulation
measurements in an open system, with corrections for diffusional losses of NO. The results
obtained using the two methods were in excellent agreement. Rates of NO synthesis (2.3 + 0.6
pmol s-1 106 cells-), NO consumption (1.3 ± 0.3 s-1), and 02 consumption (58.8 ± 17 pmol/s/10 6
cells) for activated BMDM were indistinguishable from those of activated RAW264.7 cells. NO
production rates calculated from NO2- accumulation data for HCT1 16 cells infected with
Helicobacter cinaedi (3.9 ± 0.1 pmol/s/106 cells) were somewhat greater than those of
RAW264.7 macrophages infected under similar conditions (2.6 ± 0.1 pmol/s/106 cells). Thus,
RAW264.7 cells have nearly identical NO kinetics to primary macrophages, and stimulated
epithelial cells are capable of synthesizing NO at rates comparable to macrophages. Using this
new cellular data to refine the predictions of the colon model, simulations of NO diffusion and
reaction in a crypt during inflammation gave maximum NO concentrations of about 0.2 [M.
The presence of iNOS and nitrotyrosine in human metastatic melanoma tumors suggest
that NO plays a role in the pathophysiology of metastatic melanomas. However, the
concentrations of NO that melanoma cells are exposed to in vivo remains unknown. Cellular
rates of NO synthesis and consumption were experimentally determined and used in a reaction-
diffusion model to predict NO concentrations in a cutaneous melanoma. NO synthesis by A375
melanoma cells was undetectable using Griess assays. The rate constant for intracellular NO
consumption by A375 cells (7.1 ± 1.1 s-1), was determined by monitoring NO concentrations in a
closed chamber with corrections for autoxidation and consumption from media-generated 02-.
Incorporating NO kinetic data from A375 cells and macrophages into a reaction-diffusion model,
NO was found to be localized to the periphery of the melanoma; roughly 90% of the NO
synthesized by macrophages is consumed within 30 [tm of the tumor edge. Several additional
scenarios were modeled, including the effects of varying the volume fraction of macrophages
surrounding a melanoma tumor and intratumoral NO synthesis by melanoma cells. As such, a
range of NO concentrations were predicted (< 0.2 VM) for the edge of the tumor. Our model
may offer some insight into the role NO plays in the metastasis of cutaneous melanomas, which
occurs primarily through lymphatic spread. At the melanoma edge, NO may inhibit melanoma
cell apoptosis, contributing to abnormal tumor growth and invasion of local lymph vessels or NO
may act as a lymphangiogenic factor.
The colonic crypt model and the cutaneous melanoma model developed in this work
provide the first NO concentration predictions for tissues during inflammation. Despite the
different geometries and different cell types involved, the maximum values estimated in both
cases were - 0.2 pM. The results from this work can be used for predicting intracellular levels of
other reactive nitrogen species, and should help guide further studies to understand the
mechanisms by which NO contributes to carcinogenesis in IBD and in cutaneous melanomas.
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Chapter 1. Introduction
1.1. Biological Impact of Endogenous Nitric Oxide
Nitric oxide is a biological messenger that participates in many physiological pathways.
NO is formed from the guanidine nitrogens of L-arginine via an enzymatic oxidation caused by
NO synthase (NOS) [Nathan, 1992]. The isoforms of NOS include constitutive NOS in
endothelium (eNOS) and neurons (nNOS), as well as an inducible form (iNOS). As constitutive
NOS isoforms, nNOS and eNOS exist in the cell as preformed proteins whose activity is
switched on by the elevation of intracellular Ca 2+ concentrations, resulting in relatively low
levels of NO. The expression of iNOS, on the other hand, is regulated by cytokines with enzyme
activity lasting for days or weeks, and produces a much higher level of NO. The de novo
synthesis of iNOS mRNA and protein is induced by interferon-gamma (IFN-y), a cytokine which
is most characteristic for type 1 T-helper cells [Dalton, et al., 1993].
NO plays many roles in vivo. NO acts as a vasodilator when released by the endothelium
of blood vessels and functions as a neurotransmitter and neuromodulator in the central and
peripheral nervous systems. The regulatory roles of NO in the neuronal and vascular systems
require the low levels of NO derived from nNOS or eNOS. In its protective role as part of the
immune system, however, NO is associated with the expression of iNOS and prolonged, high
NO production.
1.2. Nitric Oxide and the Immune Response
The innate immune system consists of certain types of cells and humoral factors that
recognize, inactivate, and kill infectious agents. Mechanisms of defense include the
phagocytosis of bacteria by neutrophils or macrophages and the production of nitric oxide and
superoxide. Macrophages are terminally differentiated mononuclear phagocytes that originate in
the bone marrow and pass out of blood vessels for distribution throughout the body.
Macrophages are activated when the inductive signal binds to suitable receptors on the
cell surface. One inducer, IFN-y, 'primes' macrophages; in the primed state, the macrophages
can bind to tumor cells without secreting lytic mediators. However, with the addition of
bacterial lipopolysaccharide (LPS), macrophages become fully activated, allowing the cells to
secrete factors that assist in the killing of invading microorganisms, tumor cells, or infected host
cells.
Cytokines and microbial products often act in synergistic pairs to induce expression of
iNOS. IFN-y and bacterial LPS are the prototypic, best-studied examples of iNOS inducers, and
are effective stimulators of mouse macrophages either in combination or alone. Tumor necrosis
factor (TNF) in conjunction with any of the interferons (including a and P) or interleukin 1-beta
(IL- 1/) has also been shown to elicit NO production in murine macrophages in vitro [Nathan,
1992; Pahan, et al., 1997]. Among viral and microbial products, lipoprotein of Mycobacterium
tuberculosis, the flagella of gram-negative bacteria, Salmonella typhimurium, and DNA from
various protozoan parasites have all been shown to elicit NO production by macrophages [Mori,
et al., 1999; Gao, et al, 1999; Ohashi, et al., 2000; Cherayil, et al., 2000; Shoda, et al., 2001;
Thoma-Uszynski, et al., 2001]. In addition, several noncytokine, nonmicrobial substances, such
as ozone and asbestos, induce iNOS or augment its induction [Nathan, et al., 1994].
The study of macrophage-synthesized nitric oxide evolved from early work trying to
understand the association between exposure to high levels of nitrates and gastric cancer. In
several studies, mammals maintained on low nitrate diets excreted more nitrate than ingested
[Tannenbaum et al, 1978]. In rats, treatments with Escherichia coli LPS led to approximately a
10-fold increase in urinary nitrate (NO3-) [Wagner et al, 1983], and macrophages were later
shown to be a major source of this nitrate in LPS-treated mice [Stuehr and Marletta, 1985].
Establishing LPS and IFN-y as stimulators of primary macrophage cultures, Stuehr and Marletta
also compared several murine macrophage cell lines (RAW264.7, WEHI-3, PU5-1.8, J774A. 1,
and P338D1) to peritoneal primary macrophages by measuring the synthesis of nitrite/nitrate
under these stimulatory conditions [Stuehr and Marletta, 1987]. However, nitrite or nitrate
themselves could not replicate the cytotoxicity of macrophages except at acid pH [Stuehr and
Nathan, 1989], a condition in which nitrite can generate NO. This, along with the discovery that
nitric oxide is formed as an intermediate in the L-arginine to NO 2-, NO3-, and citrulline pathway
[Marletta, et al., 1988], helped establish that macrophages synthesize nitric oxide to assist in the
killing of invading microorganisms. Use of animal model systems proved that NO produced by
macrophages in vivo was genotoxic in target tissues [Gal and Wogan, 1996].
Although activation of iNOS has been demonstrated extensively in mouse macrophages,
and even in other different types of animal macrophages, including cow [Adler et al., 1995],
horse, sheep, and goat [Jungi et al., 1996], there was debate over whether or not human
macrophages are capable of NO generation. Initial skepticism was fueled by studies showing
blood monocytes from normal American donors contain little or no functional NOS protein
[Weinberg, et al., 1993]. In vitro treatment of human peripheral blood mononuclear cells with
LPS and IFN-y also failed to elicit NO production [Schneemann, et al., 1993], even though these
stimuli are highly effective in activating murine macrophages. However, as described next, it is
now generally accepted that human macrophages produce NO.
NO production by humans was first consistently demonstrated in patients with infections
or inflammatory conditions [Dykhuizen, et al., 1996]. iNOS expression was observed within
different inflamed tissues of patients with sepsis [Annane, et al., 2000] and in macrophages from
patients with tuberculosis [Nicholson, et al., 1996], rheumatoid arthritis [St. Clair, et al., 1996],
and malaria [Anstey, et al., 1996]. Mononuclear phagocytes taken from these patients, studied
either directly or following stimulation in vitro with cytokines, were found to express iNOS.
These results suggested that NO production by human macrophages is more readily detectable
when the cells are activated in vivo. Given the biochemical evidence of NO production
[Vouldoukis, et al., 1995] and that iNOS mRNA and protein expression have been repeatedly
demonstrated in activated human macrophages [Kobzik, et al., 1993; Reiling, et al., 1994;
Weinberg, 1998], there is no longer any doubt that human monocytes and macrophages can
express functional iNOS at the protein level or that NO secretion by macrophages plays a role in
the human innate immune response. The differences in NO induction between human and rodent
macrophages may be due to species variations or from maturation and specialization of the cells;
murine studies use mature macrophages whereas studies in humans use bloodstream monocytes.
1.3. Pathophysiology of Nitric Oxide
1.3.1. Reactive Nitrogen Species formed from NO
Although NO is necessary for normal physiological function, it is cytotoxic and
mutagenic at high concentrations. Overproduction of NO has been observed in infectious or
inflammatory states of the colon, bile duct, and liver [Tamir and Tannenbaum, 1996]. While NO
can act directly, much of its cytotoxicity may be due to reactive products associated with NO.
As mentioned, under inflammatory conditions, neutrophils and macrophages produce
superoxide along with NO. Superoxide is a byproduct of cell aerobic metabolism and interaction
of molecular oxygen with free electrons from the mitochondrial electron transport chain results
in its generation [Halliwell and Gutteridge, 1989]. Although it is scavenged by superoxide
dismutase (SOD), it is present in virtually all cells [Boveris, et al., 1972; Bray, et al., 1974;
Tyler, 1975]. Superoxide is also generated by an NADPH oxidase on the external membrane
surface of macrophages, thereby contributing extracellular generation of 02- [Babior, 1984;
Berton et al., 1988]. Superoxide (02-) and other reactive oxygen species are known to cause
DNA damage from base modification and strand breaks [Trush and Kensler, 1991]. Left
unrepaired, the DNA damage may lead to permanent mutations and possibly cancer.
The rapid reaction of NO with superoxide forms peroxynitrite, ONOO-. Peroxynitrite can
cause lipid peroxidation [Radi et al., 1991] and irreparable damage to DNA, including oxidation
of bases, single-strand breaks, and DNA-DNA cross links [Burney et al., 1999; Tretyakova et al.,
2000]. Peroxynitrite also leads to the opening of the permeability transition pore in the inner
mitochondrial membrane [Packer et al, 1997], an event linked to necrosis and apoptosis [Hirsch
et al., 1997]. Consequently, ONOO- has been linked to cancer and neuro-degenerative disorders
such as Alzheimer's disease [Smith et al., 1997].
NO can also react with oxygen to form nitrous anhydride, N20 3, which is a powerful
electrophilic nitrosating agent. N20 3 may damage DNA directly through nitrosation of primary
amines on DNA bases or indirectly by nitrosating various secondary amines to form N-
nitrosamines. When metabolized, these carcinogenic ntirosamines can in turn react with DNA at
multiple nucleophilic sites and lead to deamination and cross-linking of DNA. [Tannenbaum et
al, 1994].
1.3.2. NO and Carcinogenesis
In part due to these reactive nitrogen species, excessive amounts of NO can lead to
cytotoxicity, which when chronic, results in enhanced cell replication and increased risk for
cancer. In fact, epidemiological studies demonstrate an association between chronic
inflammation and increased cancer risk [Ohshima and Bartsch, 1994]; examples include
inflammatory bowel disease and colon cancer [Levin, 1992; Farrell and Peppercorn, 1997],
Helicobacter pylori infection and gastric cancer [Asaka et al, 1997; Ebert et al, 2000], and
Schistosoma haematobium infection and bladder cancer [Badawi et al, 1995; Mostafa et al,
1999]. Thus, the damage of host tissue under prolonged exposure to high concentrations of NO,
as seen with chronic disorders, suggests a causative role for NO in the pathophysiology of these
diseases [Tamir and Tannenbaum, 1996].
Moreover, a series of studies also implicate NO in tumorigenesis [Hofseth, et al., 2003;
Crowell, et al., 2003]. For example, the incidence of gastric carcinogenesis induced by
Helicobacter pylori is decreased in iNOS-deficient mice [Nam et al., 2004]. NO may influence
tumor progression and metastasis directly by contributing to tumor-cell proliferation, migration
and invasion, and indirectly through the expression of angiogenic and lymphangiogenic factors.
Histological examinations show a correlation between high angiogenic activity or high VEGF
expression and iNOS expression in human brain [Ludwig, et al., 2000], head and neck [Gallo, et
al., 1998], lung [Marrogi, et al., 2000], breast [Vakkala, et al., 2000], stomach [Song, et al.,
2002] and colon [Ambs et al., 1998] tumors. Similarly, lower VEGF expression and slower
growth of B 16 melanomas has been observed in iNOS deficient mice, which suggests that iNOS
promotes tumor growth through induction of VEGF expression and angiogenesis [Konopka et
al., 2001].
In addition, there is evidence that iNOS expression and/or activity correlates positively
with lymph-node metastasis, which occurs from the invasion of tumor cells into the lymphatic
vessels and eventually the lymphatic system. Clinical studies suggest that NO is involved in this
process in several types of tumors including head and neck [Franchi, et al., 2006], breast
[Nakamura et al., 2006], melanoma [Massi, et al., 2009], and gall-bladder tumors [Niu, et al.,
2004], whereby NO exposure induces vascular endothelial growth factor C (VEGFC) expression.
VEGFC is a putative lymphangiogenic factor that mediates lymphangiogenesis and metastasis
[Alitalo, et al., 2002]. Thus there exists a growing body of evidence that indicates NO has a role
in the regulation of tumorigenesis, tumor angiogenesis and lymphangiogenesis, progression and
metastasis.
1.4. Existing Models for NO
The first mathematical models for the biotransport of nitric oxide calculated
concentration profiles by modeling one-dimensional diffusion of NO generated from point
sources [Lancaster 1994, Wood and Garthwaite, 1994]. Approximating the reaction of NO as
first order, Lancaster found that NO could diffuse to significant concentrations over fairly long
distances. Similarly, Wood and Garthwaite (1994) modeled the diffusion of NO generated in
neurons as either single or multiple point sources in the brain. The results from their model
suggested that a single point source of NO could influence approximately two million synapses
by diffusion to a volume of brain tissue 200 jm in diameter. Both of these works were significant
in elucidating NO's diffusive capabilities but had limitations as one-dimensional point-source
models. More extensive models considered the geometrical structure of NO sources as important
factors in the diffusion process. Philippides, et al. (2000) modeled NO diffusion from hollow
spherical neurons in the brain. Vaughn, et al. modeled the diffusion of NO produced in
endothelium into surrounding tissue using both first order and second order decay terms (1998).
However, these models are for scenarios in neuronal signaling and in the endothelium; when the
research in this thesis began, there were no existing models for nitric oxide production in tissue
during the immune response.
Although there were no previous models for NO in inflamed tissue, reaction-diffusion
models have been developed to predict NO concentrations in various cell culture experiments.
In particular, Chen and Deen (2002) described spatial and temporal changes in NO, 02-,
peroxynitrite, and N20 3 concentrations for macrophages in plated cell culture configurations.
Nalwaya and Deen (2004) incorporated additional factors in modeling NO and 02 concentrations
for activated macrophages in plated cell culture, including the inhibitory effect of NO on
respiration. The reactions involving NO and 02 in these cell culture experiment models are also
used for estimating NO levels in tissue. Moreover, it was shown that unlike NO, which is more
diffuse, the fast chemical kinetics of reactions involving 02- and peroxynitrite are such that their
concentrations are confined to small regions near the cells. As such, NO levels in tissue can be
estimated independently from the complex reaction schemes involving other reactive nitrogen
species. Once the tissue concentrations of NO are estimated, the concentrations of other reactive
NO products can be calculated separately using detailed intracellular models [Lim, et al., 2008].
1.5. Known Cellular Kinetic Rates
1.5.1. NO Synthesis by Macrophages
The rates at which cells synthesize or consume NO is critical for predicting NO
concentrations in tissue during inflammation. Of the macrophage cell lines that Stuehr and
Marletta studied, RAW 264.7 cells were shown to synthesize nitrite and nitrate at rates similar to
those of primary macrophages [Stuehr and Marletta, 1987]. Subsequently, RAW cells became
commonly used in lieu of primary macrophages in NO toxicity studies [Lewis and Deen, 1995;
deRojas-Walker et al, 1995; Nalwaya and Deen, 2004; Nalwaya and Deen, 2005]. The specific
activation conditions of RAW 264.7 cells in plated cell cultures has been well characterized; the
effects of cell density, varied LPS- and IFN-y concentrations [Zhuang and Wogan, 1997], liquid
depths [Chen and Deen, 2002], and activation times [Lewis and Deen, 1994] have all been
investigated. With these established stimulation conditions, several studies have determined
nitric oxide synthesis in activated macrophage cultures by measuring concentrations of nitrite
and nitrate, the main products of NO oxidation [Marletta et al, 1988; Lewis and Deen, 1994;
deRojas-Walker et al, 1995]. One limitation of this approach is that NO production by cells may
be underestimated because it assumes that NO diffusion out of the liquid is negligible. In reality,
the diffusional loss of NO to the headspace is usually quite significant in typical plate culture
systems [Chen and Deen, 2001]. Using a closed chamber fitted with NO and 02 sensors,
Nalwaya was the first to use time-dependent NO and 02 concentrations simultaneously in plated
RAW 264.7 cell cultures to determine NO kinetic rates more directly [Nalwaya and Deen, 2005].
However, it remained unclear how NO kinetic rates of macrophage-like RAW264.7 cells
compare with those of primary macrophages.
1.5.2. NO Synthesis by Cells other than Macrophages
Colonic biopsies from patients with inflammatory bowel diseases show pronounced
expression of iNOS in the colonic epithelium [Rachmilewitz, et al., 1995] but little is known
about the regulation of iNOS activity in colonic epithelial cells. Under basal conditions, minimal
quantities of NO are produced in the colonic epithelium, as evidenced by nitrite and nitrate
accumulation measured in cultured colonic explants [Rachmilewitz, et al., 1995; Ribbons, et al.,
1995]. Because epithelial cells in healthy mucosa do not express iNOS, it is believed that
enzyme activity is also induced by cytokines released in the inflamed tissue; time course studies
have demonstrated a time-dependent expression of iNOS mRNA, first observed at 6 hours and
maximal at 24 hours after cytokine exposure [Dignass et al, 1995]. Cultured primary colonic
epithelial cells harvested from rats and HT-29 human colonic epithelial cells express iNOS and
generate increased levels of NO in response to stimulation by IFN-y and LPS, as well as other
cytokines such as IL-la, TNF-u, and enteroinvasive E. coli [Dignass et al, 1995; Witthoft et al,
1998; Kolios et al, 1998; Wright et al, 1999]. However, rates of NO production, inferred from
these reported nitrite accumulation rates vary by some two orders of magnitude [Witthoft et al,
1998; Wright et al, 1999], with the upper end of these rates corresponding to NO synthesis that is
roughly an order of magnitude less than that of macrophages [Nalwaya and Deen, 2005]. The
uncertainty over the rates of colonic epithelial cell NO synthesis may be attributed to variable
experimental setups, such as unreported liquid depths of the culture media, which can affect the
diffusional loss of NO and the inferred NO synthesis rates. Regardless, the data do support the
notion that proinflammatory cytokines or bacteria induce NO production in colonic epithelial
cells.
Metastatic melanoma tumors excised from patients have been shown to express low
levels of iNOS [Ekmekcioglu, et al., 2000]. In vitro studies have also established positive iNOS
expression in A375 and MeWo human melanoma cell lines [Zheng et al., 2004], primary
melanoma cells isolated from metastatic lesions, and in normal adult melanocytes [Salvucci et
al., 2001]. However, despite demonstrating iNOS expression in A375 and MeWo cells, Zheng et
al. (2004) found that levels of nitrite accumulation were barely detectable. Other studies have
also reported negative Griess results for melanoma cells in culture, including K-1735 C4 murine
metastatic melanoma cells [Xie et al., 1995] and G361, a human melanoma cell line [Andrews et
al., 1995]. Thus, it remains unclear whether melanoma cells actually produce NO from iNOS;
melanoma cells have also been shown to express the other constitutive isoforms of nitric oxide
synthase (eNOS and nNOS), [Salvucci et al., 2001; Ahmed and Van Den Oord, 1999] which
may contribute to low levels of NO production.
1.5.3. Cellular NO consumption
Another consideration in measuring rates of NO synthesis is that cells also consume NO.
In addition to the reaction between NO and superoxide, which occurs in all cells, NO may also
be consumed via enzymatic pathways. For instance, NO dioxygenase (NOD) is responsible for
the oxidation of NO to NO3- in certain mammalian cells [Gardner et al, 2000]. NO may also react
with oxygen-ligated reduced metals to produce NO3- and the oxidized metal [Eich et al, 1996].
Measurements of NO consumption by rat hepatocytes indicate that the overall intracellular NO
consumption rate via these various mechanisms can be modeled as being first order in NO
concentration [Thomas et al, 2001]. The extent that any of these mechanisms occur in cells will
tend to limit the maximum achievable NO concentration. The rates of NO consumption
measured for a variety of cell types are summarized in Table 1.1. The wide range of values is
likely to stem from differences in cell types as well as the variations in cell culture and growth
conditions. Most of the cells listed in Table 1.1 are adherent cells grown on tissue culture plates,
with the exception of TK6 and NH32, which are grown in suspension, and Caco-2 cells, which
are grown on semi-permeable filters.
1.5.4. Oxygen consumption
Respiration rates (R,,,ax) have been measured for a variety of mammalian cell types. 02
consumption rates for different hybridoma cell types are reviewed by Ruffieux et al. (1998); the
average 02 uptake rate from the eleven studies surveyed was 55 pmol/s/10 6 cells. In addition,
several other mammalian respiration rates have been measured, and are listed in Table 1.2. As
seen, the rates of respiration by the various cell types are all on the same order of magnitude and
fall in the range between -20 to 60 pmol/s/106 cells.
1.5.5. Extracellular Superoxide Production
The synthesis of extracellular superoxide by macrophages involves NADPH, a plasma-
bound enzyme. The release of superoxide occurs upon phagocytosis of bacteria and assists in the
subsequent killing of the ingested microorganisms. Stimulated production of 02 was first
described as a "respiratory burst" because the release of superoxide during phagocytosis
corresponded to an observed increase in cellular oxygen consumption [Drath and Karnovsky,
1975]. While the respiratory burst typically continues for a few minutes after activation (and can
last for as long as one hour) in certain types of macrophages [Berton, et al., 1988], superoxide
synthesis has been shown to remain constant for up to three days with constant stimulation
[Johnston, et al., 1978]. Activators for superoxide production in macrophages include phorbal
12-myristate 13-acetate (PMA) [Auger and Ross, 1992], zymosan, as well as IFN-7 or the
combination of IFN-y and LPS [Nathan, et al., 1983; Nathan, et al., 1984; Murray, et al., 1985].
Moreover, unlike stimulation of nitric oxide production, there is no apparent time lag for cellular
02- synthesis [Johnston, et al., 1978; Chen and Deen, 2002; Nalwaya and Deen, 2005]. Murine
resident peritoneal macrophages (PM) have been shown to generate O2- under control conditions
at either negligible or very low rates [Drath and Karnovsky, 1975; Johnston, et al., 1975].
Table 1.1. Comparison of rate constants for intracellular NO
mammalian cell types
Cell Cell Type kc (s"1) Reference
NH32 Human lymphoblast 0.1 C. Wang, 2003
TK6 Human lymphoblast 0.3 C. Wang, 2003
RAW264.7 Macrophage 0.6 Nalwaya and Deen, 2005
3TC3 Pancreatic p 1.7 C. Wang, 2003
K9 Rat hepatocyte 2 Gardner et al., 2001
PC 12 Rat adrenal 4 Gardner et al., 2001pheochromocytoma
K562 Human myelogenous 5 Gardner et al., 2001leukemia
MLE Murine lung epithelial 9 Gardner et al., 2001
A549 Human lung 9 Gardner et al., 2001
adenocarcinoma
Caco-2 Human colonic epithelial 38 Gardner et al., 2001
consumption by various
Table 1.2. Comparison of oxygen consumption rates by various mammalian cell types.
Cell Type R
Hybridoma cells
Rat hepatocyte
Rat adrenal pheochromocytoma
Human myelogenous leukemia
Murine lung epithelial
Human lung adenocarcinoma
Human colonic epithelial
Unactivated murine macrophage
Unactivated murine macrophage
a s 106 cells
55
33
33
17
57
43
42
16
33
Reference
Ruffieux, et al., 1998
Gardner et al., 2001
Gardner et al., 2001
Gardner et al., 2001
Gardner et al., 2001
Gardner et al., 2001
Gardner et al., 2001
Brown et al., 1998
Nalwaya and Deen, 2005
Cell
various
K9
PC12
K562
MLE
A549
Caco-2
J774.1
RAW264.7
--
Table 1.3. Comparison of reported 02 formation rates for primary murine macrophages
02 formation
Cell Stimulant (pmol/mg Reference
protein/min)
PM none 0.08 Drath and Karnovsky, 1975
PM zymosan 1.07 Drath and Karnovsky, 1975
PM none 0.002 Johnston, et al., 1978
PM zymosan 0.16 Johnston, et al., 1978
J774 zymosan 0.07 Johnston, et al., 1978
PU5-1.9 zymosan 0.06 Johnston, et al., 1978
P388D1 zymosan 0.03 Johnston, et al., 1978
Human zymosan 0.2 Johnston, et al., 1978
monocyte
BMDM IFN-y + zymosan 0.78 Phillips and Hamilton, 1989
BMDM LPS +zymosan 0.38 Phillips and Hamilton, 1989
Abbreviations: PM, peritoneal macrophages; BMDM, bone marrow-derived macrophages; IFN-
y, interferon-y; LPS, E. coli lipopolysaccharide.
Table 1.4. Comparison of reported 02 formation rates for murine RAW264.7 macrophages and
human monocytes.
Cell Type and Stimuli
Human monocyte + PMA
RAW264.7 + IFN-y + LPS
RAW264.7 + IFN-y + LPS
RAW264.7 + IFN-y + LPS
RAW264.7 + IFN-y + LPS
RAW264.7 + IFN-y + LPS
RAW264.7
RAW264.7 + IFN-y + LPS
02
formation(pmol
s 106 cells
0.35
0.05
2.9
0.3
0.33
0.3
0.5
1.33
Reference
Johnston, et al., 1976
deRojas-Walker, et al., 1995
Lewis, et al., 1995
Chen and Deen, 2002
Nalwaya and Deen, 2005
Kim and Wogan, 2006
Brune et al., 1997
Brune et al., 1997
Exposure to zymosan and PMA generates a heightened 02- response in PM and bone
marrow-derived macrophages (BMDM). The generation of 2O can also be elicited by pre-
exposing BMDM to certain cytokines, including granulocyte-macrophage colony stimulating
factor (GM-CSF), TNF-a, IFN-y, bacterial LPS, and, to a lesser extent, IL-lca prior to exposure to
zymosan [Phillips and Hamilton, 1988]. The rates of superoxide synthesis in these studies are
listed in Table 1.3, along with formation rates measured for murine macrophage cell lines
(J774.1, PU5-1.9, and P388D1) and human monocytes. From Table 1.3, it is seen that the
superoxide synthesis rates for human monocytes, murine peritoneal macrophages and bone
marrow-derived macrophages are all within the same order of magnitude. The rates of
superoxide synthesis for RAW264.7 cells, quantified on a pmol/s/10 6 cell basis, are listed in
Table 1.4. In these studies, activation was achieved by stimulating macrophages with IFN-y and
LPS; the variations in earlier reported rates [Lewis, et al., 1995; Brune et al., 1997], spanning 2
orders of magnitude, may be attributed to variations in cell culture media. In particular,
riboflavin (under laboratory lighting) and HEPES buffer, two ingredients in media, are known
producers of superoxide [Keynes, et al., 2003]. Interestingly, the other reported rates of
superoxide synthesis by Chen and Deen (2002), Nalwaya and Deen (2005), and Kim and Wogan
(2006), -0.3 pmol/s/106 cells, are in good agreement with superoxide synthesis rates reported for
primary human monocytes.
1.6. Objectives
Despite numerous models for NO in vascular or neural contexts, none existed for iNOS-
produced NO and the concentrations of NO in tissue during infection or inflammation remained
unknown. In particular, nitric oxide production has been linked to inflammatory bowel disease
(IBD) and increased risk for cancer in the colon, where measurements of NO concentration pose
significant technical challenges, and it is unclear what NO levels are pathophysiological.
Consequently, the first objective of this thesis was to develop a model to predict NO
concentrations in the colonic crypts during inflammation. As presented in Chapter 2, a
computational approach, based on anatomical length scales and rates of NO production measured
in cell cultures, was used to predict NO concentration profiles for a variety of scenarios within
the crypt during inflammation.
The second objective was to characterize NO, 02, and 02- production and consumption
rates for a macrophage cell line, primary macrophages and colonic epithelial cells, as described
in Chapter 3. These kinetic rates are critical parameters for modeling NO concentrations in
tissue during inflammation and are also useful for predicting intracellular levels of other reactive
nitrogen species that may contribute to cytotoxicity and mutagenesis. Although the rates of NO
synthesis and consumption for RAW264.7 cells are known [Nalwaya and Deen, 2005], there
may be differences between the murine macrophage-like cell line and primary macrophages.
Significant variations in reported NO synthesis rates by colonic epithelial cells also warranted
further characterization of their kinetic rates.
The third objective, described in Chapter 4, involved characterization of cellular kinetic
rates and NO concentration predictions in a different disease - melanoma. The presence of
iNOS and nitrotyrosine in human metastatic melanoma tumors has been correlated with poor
survival rates in patients but the concentrations of NO that melanoma cells produce and are
exposed to in vivo remains unknown. Although it has been shown that A375 and MeWo
melanoma cells express iNOS in vitro [Zheng et al., 2004], it remains unclear whether or not the
cells actually produce measurable levels of NO and the rates of NO consumption have not been
reported. NO kinetic rates in melanoma cells were determined by monitoring NO concentrations
in a closed chamber apparatus, like that employed for macrophage and epithelial cells studies,
and were subsequently incorporated into a model that predicts NO concentrations in a cutaneous
metastatic melanoma.
Chapter 2. Predicting Nitric Oxide Concentrations in the Colonic Crypt During
Inflammation
2.1. Introduction
The relationship between the chronic inflammation of inflammatory bowel disease and
colon cancer has been demonstrated directly in experimental animals; for example, Citrobacter
rodentium infections produce lesions similar to those of IBD and have been shown to promote
colonic adenomas in lines of targeted gene mutant mice [Newman et al, 2001]. Although the
precise etiology of IBD remains to be elucidated, there is a growing body of both experimental
and clinical evidence that links chronic gut inflammation with enhanced production of nitric
oxide. Evidence for increased synthesis of NO has been reported in patients with active
ulcerative colitis, with either increased inducible nitric oxide synthase (iNOS) activity
[Boughton-Smith et al, 1993; Lundberg et al, 1994; Middleton et al, 1993] or increased intestinal
luminal NO concentrations [Herulf et al, 1998]. Thus, NO generated by iNOS activity is likely to
contribute to the increased vascular permeability and tissue injury seen in active IBD. This is just
one example of a more general linkage between chronic inflammation, sustained NO
overproduction, and various forms of cancer, and several pathways for NO-induced damage to
tissue cells have been proposed as possible mediators [Tamir and Tannenbaum, 1996]. Among
the most likely damaging agents are reactive nitrogen species derived from NO, including
nitrogen dioxide (NO2), nitrous anhydride (N20 3), and peroxynitrite (ONOO-).
As shown in Figure 2.1, the inner lining of the colon, or mucosa, consists of three distinct
layers: the muscularis mucosa, the lamina propria, and the epithelium. The lamina propria forms
the connective tissue that surrounds tubular invaginations, known as colonic crypts. Lined with
an epithelial layer that is one cell thick, the crypts are filled with intestinal luminal fluid and
luminal fluid
Figure 2.1. Schematic representation of colonic crypt anatomy.
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surrounded by an intricate network of blood capillaries. Under normal circumstances,
intraluminal microbes do not elicit an inflammatory response, but rather coexist with the
epithelium. During an infection, however, macrophages migrate to the sites of microbial
invasion as part of the immune response, where the NO they synthesize may assist in killing the
invading microorganisms. Thus, macrophage populations are distributed within the mucosa [Pull
et al, 2004], as depicted on the right in Figure 2.1. With the onset of IBD, the mucosa becomes
inflamed and ulcers may form in the colon. IBD is also associated with increased epithelial
permeability to solutes such as ovalbumin and mannitol [Nejdfors et al, 1998].
Immunohistochemical staining of samples taken from patients with active ulcerative colitis show
that significant iNOS reactivity is localized in the crypt epithelium and in macrophages
aggregated around crypt abscesses [Kimura et al, 1998; Singer et al, 1996], suggesting that both
cell types are sources of NO.
The apparent linkage between NO and the pathogenesis of IBD notwithstanding, it is
unknown what concentrations of NO in the colon are pathophysiological. The same may be said
for other inflamed tissues. In the colon and elsewhere, estimates of NO concentration are needed
to quantify levels of other potentially damaging reactive nitrogen species and to identify the most
likely mechanisms of chemical damage to host cells. The measurement of tissue NO
concentrations in vivo is technically difficult, so computational models are often the most
practical option for estimating NO levels. By describing rates of reaction and diffusion in
realistic geometries, NO concentration distributions can be inferred with reasonable confidence.
No such models have been available for the colon. Accordingly, we used a computational
approach, based on anatomical length scales and rates of NO production measured in cell
cultures, to predict NO concentration profiles within a colonic crypt during inflammation. A
variety of scenarios were considered, including a range of possible macrophage and epithelial
synthesis rates for NO and various spatial distributions of macrophages.
2.2. Model Formulation
2.2.1. Geometric Assumptions
The model was based on a single murine colonic crypt, which was approximated as the
axisymmetric structure shown in Figure 2.2. Intestinal luminal fluid or mucus (volume V1) is
surrounded by an epithelial cell layer (V2). A layer of macrophages lines the bottom of the crypt
(V4 ). The entire region is bounded on the side and bottom by blood vessels (surfaces S4 and S5).
The spaces between the epithelium and crypt capillaries, and between the macrophage layer and
blood vessels of the muscularis mucosa, represent lamina propria tissue (V3 and Vs, respectively).
The surfaces St (luminal fluid), S2 (epithelium), and S3 (lamina propria) define the top of the
crypt.
The epithelium is assumed to be one cell thick [Singer et al, 1996], with cells having an
average diameter of 5jxm [Lipkin, 1985]. In addition, the radial distance from the center of the
crypt to the surrounding capillaries is approximately 45 pm [McLaren et al, 2002], as seen in
rats. Assuming the same relative dimensions as those in humans [Araki et al, 1996], the vertical
extent of these capillaries was estimated to be roughly 125 tm, which gives a distance of 25 plm
between the bottom of the crypt and the blood vessels of the submucosa. The macrophages are
approximated as a monolayer of cells, with average diameters of 15 tm [Leskovar et al, 2000] .
These assumptions, along with known murine colonic crypt widths (15 ptm) [Paulsen et al, 2000]
and depths (100 jtm) [Drucker et al, 1999] were used to calculate the six anatomical dimensions
(three radii and three layer thicknesses) listed in Table 2.1.
luminal fluid
lamina propria
epithelium ,
macrophages
blood vessel
S3 S2 S1
Figure 2.2. Geometrical representation of colonic crypt used in model.
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Table 2.1. Linear Dimensions for Murine Colonic Crypt
Variable Value
RI 15 tm
R2 20 tm
R3 45 m
Lc 100 pm
LM 15 pm
LT 10 pm
2.2.2. Reactions of Nitric Oxide in Tissues
The main source of NO in IBD was presumed to be iNOS in the macrophages and
epithelial cells. NO production by endothelial cells was assumed to be negligible. Once
synthesized, NO diffuses out of the cells, because the cell membrane permeability to NO is very
high, similar to that of 02 [Subczynski et al, 1996]. The following reactions determine the
subsequent fate of NO: autoxidation, intracellular consumption, and oxidation by
oxyhemoglobin.
The uncatalyzed reaction of NO with molecular oxygen, termed "autoxidation," yields
nitrite (NO2-) as the end product, with NO 2 and N20 3 formed as intermediates [Lewis et al,
1995]. The overall stoichiometry of this multi-step oxidation is
4NO+0 2 + 2H20 -4NO+4H + . (2.1)
This reaction will occur both within cells and in extracellular spaces such as intestinal luminal
fluid. However, as will be shown, it is too slow to have a significant effect on NO
concentrations in intestinal crypts.
Various pathways exist for the intracellular consumption of NO. One involves its rapid
reaction with superoxide (02-) to form ONOO- and (mainly) nitrate (NO3-) [Huie and Padmaja,
1993; Ischiropoulos et al, 1992]:
NO + 02- --> ONOO- co2 4 NO3. (2.2)
Because 02 is a byproduct of respiration and Reaction 2.2 is fast enough to compete with
superoxide dismutase, it is expected to occur in virtually all cells. In addition, NO may be
consumed via enzymatic pathways. For instance, NO dioxygenase (NOD) is responsible for the
oxidation of NO to NO3- in certain mammalian cells [Gardner et al, 2000]. NO may also react
with oxygen-ligated reduced metals to produce NO3- and the oxidized metal [Eich et al, 1996].
Measurements of NO consumption by rat hepatocytes indicate that the overall intracellular NO
consumption rate via these various mechanisms can be modeled as being first order in NO
concentration [Thomas et al, 2001].
It should be noted that Reaction 2.2 also leads to a certain amount of extracellular
consumption of NO. That is, while synthesizing NO via iNOS, activated macrophages also
steadily generate extracellular 02-, due to a membrane-bound NADPH oxidase [Lewis et al,
1995; Chen and Deen, 2002; Nalwaya and Deen, 2005]. Accordingly, near an activated
macrophage, some NO will be converted to ONOO-. However, the diffusion-limited kinetics of
Reaction 2.2, together with the fact that NO production exceeds extracellular 02- synthesis,
makes this an extremely localized process. It has been estimated that the 02 produced by a
macrophage is fully exhausted within 1 Cpm of the cell [Chen and Deen, 2002]. Moreover, the
rate of 02 release into the media by a macrophage has been found to be only 6% of its rate of
NO production [Nalwaya and Deen, 2005]. For these reasons, extracellular consumption of NO
by 02- may be neglected in modeling NO concentrations in crypts.
Any NO that reaches blood vessels is depleted by its very rapid reaction with
oxyhemoglobin (HbO 2) to form methemoglobin (metHb) and NO3- [Eich et al, 1996]:
NO + HbO2 -4 metHb + NO. (2.3)
Accordingly, capillaries will act as very effective sinks for NO generated within an inflamed
tissue.
2.2.3. Conservation Equation for NO
We are concerned with inflammatory processes that persist for weeks or longer. Also,
the time required for an epithelial cell to travel from the base to the top of a crypt is 3-8 days in
humans and 2-3 days in rodents [Lipkin, 1985]. In contrast, the time required for NO to diffuse
over the lengths shown in Table 2.1 is < 1 min. Thus, a steady-state assumption was warranted,
and the concentration of NO within each region of the crypt was governed by
DNO V 2CNO + RNO = 0 (2.4)
where CNO is the concentration of NO, DNO is its diffusivity, RNO is its net rate of formation by
chemical reaction on a volumetric basis (e.g., mol m-3 s- ), and V2 is the Laplacian operator.
Equation 2.4 expresses the balance between local rates of production and diffusion of NO, and
assumes that the diffusivity is constant within a given region [Deen, 1998]. In subsequent
expressions, the diffusivities and concentrations in the luminal fluid (DNO , CNO) are
distinguished from those in the epithelium (DNO, CNO), the lamina propria tissue (DNO, CNO)
and the macrophage layer ( Duo, Cuo), as needed.
Taking into account NO synthesis and the consumption processes already discussed, the
reaction rate for NO is
RNO = k, -kCCNO 4kaCNO C 0 2  (2.5)
where kg is the generation term (assumed to be constant in a given region), kc is the overall first-
order rate constant for intracellular consumption, and ka is the rate constant for autoxidation.
Implicit in the generation and intracellular consumption terms in Eq. 2.5 is the assumption that
02 levels are high enough so as not to be limiting. Whereas autoxidation occurs in all the
regions defined above, intracellular consumption is absent in the luminal fluid (V1), and in the
baseline model NO synthesis was assumed to be confined to the epithelial and macrophage
layers (V2 and V4). The reaction of NO with HbO 2 was accounted for in the boundary conditions
at S4 and S5 (see below), and thus does not appear in Eq. 2.5.
The general governing equations for NO were obtained by using Eq. 2.5 to evaluate the
reaction rate in Eq. 2.4. For purposes of simplification and numerical solution, it was
advantageous to employ scaled dimensionless concentrations defined as 0 = CNO / CNO
and Vf = Co2 C* . The concentration scale for oxygen (C ) is the 02 concentration in venous
blood, whereas that for nitric oxide ( CNO) was identified as described later. The dimensionless
conservation equation was
k, gL2  kf .L 4kC L2V2+ + k 2 = 0 (2.6)
DNOCNO DNO DNOCo2
where L is the length scale for a particular region (see below). Although the same symbol is
used as before, V2 in Eq. 2.6 is now dimensionless (i.e., L2 times that in Eq. 2.4).
2.2.4. Boundary Conditions
The boundary conditions used in most of the simulations involved specified NO
concentrations at all external surfaces. Given the gas-phase intestinal luminal NO concentrations
measured in humans (-500 ppb) [Herulf et al, 1998] and the aqueous solubility of NO, the NO
concentration in the luminal fluid is -0.8 nM, which can be considered negligible. Likewise, the
fast reaction between NO and HbO2 [Eich et al, 1996] is expected to yield negligible NO
concentrations at the boundaries corresponding to blood vessels. The measured NO
concentration in blood plasma is approximately 1-5 nM [Stamler et al, 1992], which is much
smaller than the maximum tissue concentrations obtained in our simulations. NO synthesis in
endothelial cells may lead to somewhat higher concentrations immediately outside blood vessels,
but these have been estimated to be less than 50 nM [Lamkin-Kennerd et al, 2004]. Thus, the
endothelial contribution was generally neglected and in most of the calculations the blood
vessels were modeled as perfect sinks for NO. Accordingly, the boundary conditions used at
each of the surfaces S1 through Ss were
0 =0. (2.7)
At all internal boundaries (i.e., where V1 through V5 meet one another), the NO concentration and
flux were each assumed to be continuous.
2.2.5. Parameter Values
The length scales, diffusivities, and kinetic constants for the regions are discussed now,
as their values lead to a significant simplification of Eq. 2.6. The length scales, L, for each of the
regions were chosen as the respective radii or layer thicknesses: R 1 for VI, R 2 - R1 for V2, R 3 - R2
for V3, LM for V4, and LT for Vs. Each of these lengths was calculated from the dimensions listed
in Table 2.1. The other baseline parameter values are given in Table 2.2; unless otherwise stated,
all calculations were done using these values. The diffusivity of NO in the luminal fluid was
equated with that measured in water [Zacharia and Deen, 2005]. In each of the cellular regions
the NO diffusivity was taken to be two-thirds of its aqueous value, which is the
intracellular/aqueous diffusivity ratio for 02 [Ellsworth and Pittman, 1983]. Use of the oxygen
diffusivity ratio is justified by the nearly identical diffusional characteristics of NO and 02 in
water [Zacharia and Deen, 2005].
The rates of NO production and consumption for macrophages in Table 2.2 are based on
direct measurements in RAW264.7 murine macrophage-like cells activated with recombinant
mouse interferon-y (IFN-y) and Escherichia coli lipopolysaccharide (LPS). Cellular kinetic
parameters were determined by monitoring time-dependent NO and 02 concentrations in a closed
chamber and fitting data to a detailed kinetic model [Nalwaya and Deen, 2005]. Reported rates
Table 2.2. Baseline Values of Diffusivities, Rate Constants, and Concentrations
Parameter
DNO
NO , DNO, DNO
D21 Do , , Do,
ka
ks
k,
kc
kr
C NO
C*
O2
Value
3.0 x 10-5 cm2/s
2.0 x 10-5 cm2/s
2.8 x 10-5 cm 2/s
1.9 x 10-5 cm2/s
2.6 x 106 M-2/s
0.3 tM/s
5.6 [tM/s
0.6 s-
30 iM/s
0.63 IM
58 IM
of NO production by colonic epithelial cell lines, determined less directly, vary by some two
orders of magnitude [Witthoft et al, 1998; Wright et al, 1999]. The value given in Table 2.2 is at
the high end of the reported range. Epithelial cell NO synthesis rates were estimated based on
data collected by Witthoft et al. (1998), whereby NO production from HT-29 cells was measured
24 hours after stimulation with enteroinvasive E. coli. Assuming that all NO was converted to
NO2- and given that 300 jtM of NO2 was measured for approximately 106 cells in 1 mL of liquid
media, a volumetric rate of NO synthesis was calculated. The rates of NO consumption by
epithelial and lamina propria cells were assumed to be equivalent to those in macrophages. It
has been found, for example, that NO consumption rates in TK6 cells (a human lymphoblastoid
cell line) are roughly the same as those in RAW264.7 cells [Nalwaya and Deen, 2005; Wang et
al, 2003]. The concentration scale for 02 corresponds to an average value in venous blood.
Although not used in the calculation of NO concentrations, the intracellular diffusivity of
oxygen and the cellular 02 consumption rates in the crypt are also listed in Table 2.2, and their
implications will be discussed later. The intracellular 02 diffusivity in Table 2.2 corresponds to
two-thirds of the aqueous value [Goldstick and Fatt, 1970]. In vitro measurements show that
oxygen consumption in activated RAW264.7 cells [Nalwaya and Deen, 2005] is similar to rates
of consumption in HT-29 colonic epithelial cells [Leschelle et al, 2000]. Moreover, both of these
values are approximately equal to the reported average 02 consumption rate measured for a
variety of mammalian cell types (3 nmol/min/106 cells) [Ruffieux et al, 1998]. Accordingly, the
02 consumption rates in the macrophage layer, epithelium, and lamina propria regions are
approximated as being equal.
Given that CNO = 0 at all external surfaces in the idealized crypt (Eq. 2.7), the
concentration scale for NO will be determined primarily by the rate of NO synthesis. Assuming
that NO is produced mainly in the macrophage layer, and that NO loss from that layer is largely
by diffusion, we set the coefficient of the first reaction term in Eq. 2.6 equal to unity for that
region. The result is the value of CNO given in Table 2.2. As will be shown, our numerical
simulations confirmed that this is a good estimate of the maximum order of magnitude of CNO in
the crypt.
2.2.6. Simplified Conservation Equation
The coefficient of the autoxidation term in Eq. 2.6 is a Damk6hler number that measures
the importance of autoxidation relative to diffusion. It is denoted as
4k C C* 2
Y =N (2.8)DNO
It was found that y<< 1 in each of the five regions, ranging from a minimum of 4.8 x 10-6 in V2
to 1.2 x 10-4 in V3. This indicates that autoxidation does not significantly affect the NO
concentration in any of the regions. With the autoxidation rate being the only reaction term in
Eq. 2.6 that depends on the 02 concentration, and with that term negligible in all regions, it was
unnecessary to compute 02 concentration variations. That is, it was sufficient to focus on the
NO concentration field alone. The simplified conservation equation for NO is
V 20 + a - O0 = O (2.9)
where the remaining Damkihler numbers (for synthesis and intracellular consumption,
respectively) are
k ,L2
a = ! (2.10)
DNoCNo
P= E (2.11)
DNO
As already mentioned, we identified the NO concentration scale by setting a= 1 in the
macrophage layer (V4). Also, the assumed absence of NO generation in the luminal fluid (V1)
and lamina propria (V3, Vs) implies that a= 0 there. In the epithelium (V2) we calculated that a
= 6.9 10 5 , indicating that for our baseline conditions, epithelial NO synthesis was negligible.
This conclusion seems conservative because, as already noted, the epithelial synthesis rate in
Table 2.2 is at the high end of reported values. Intracellular NO consumption was found to be of
marginal importance for the base case, with/ ranging from 0.01 in V2 to 0.28 in V3.
Although the synthesis and intracellular consumption terms were sometimes negligible,
Eq. 2.9 (with region-specific values of a and 6) was used for all four cellular regions. Further
simplification of Eq. 2.9 for some regions did not provide any computational benefits. Also,
retaining the a and 8 terms in all regions provided the flexibility to consider hypothetical
conditions in which one or both were important, such as with higher assumed rates of epithelial
synthesis.
2.2.7. Solution Methods
The geometry depicted in Figure 2.1 was defined in a commercial finite element package
(COMSOL v.3.0, Stockholm, Sweden) using the graphical user interface. The nondimensional
differential equation (Eq. 2.9), boundary conditions (Eq. 2.7), and parameter values (a and /)
were specified for each subdomain. The system of equations was solved in the 'Diffusion'
multiphysics application mode using a linear solver (UMFPACK) and the default settings. The
initial mesh plus one mesh refinement, generating 5316 elements, was found to be adequate;
additional refinement to 21,264 elements led to a change of less than 0.01% in the NO
concentration values.
To verify the accuracy of the finite element results, a simplified model was solved
analytically using an eigenfunction expansion. For this purpose, the crypt geometry was
simplified by reducing it to a cylinder with a layer of macrophages at the bottom; the dimensions
(crypt radius, crypt depth, macrophage layer thickness) were the same as those listed in Table
2.1. Assuming the analytical results to be exact, the norm of the relative error in the numerical
solutions was calculated for this simplified model. This relative error was found to be < 0.4%,
indicating that the solution generated by COMSOL was satisfactory.
2.3. Results
2.3.1. NO Concentration Profiles
Figure 2.3 shows NO concentrations as a function of height at three radial positions, as
calculated with the baseline model parameters. In this and subsequent plots, z is height relative
to the top of the macrophage layer; thus, z = 0 at the base of the crypt and z = Lc at the top. The
radial positions r = 0, 18, and 32 pm correspond to the center of the luminal fluid, the middle of
the epithelium, and the middle of the lamina propria region (V3), respectively. As shown, the
predicted NO concentration at each radial position declines rapidly in going from the base of the
crypt to the top, the maximum concentration (at r = 0 and z = 0) being 0.29 PjM. Most of the NO
generated at the base of the crypt diffuses away radially (into the crypt capillaries) or is
consumed by cells in the lamina propria. Thus, at z = 50 jam, or halfway up the crypt, there is
more than a 90% reduction in the NO concentration. The concentration calculated for the
epithelium is very similar to that in the luminal fluid. This is a consequence of the rates of NO
synthesis and consumption in the epithelium being negligible. Concentrations in the lamina
propria are lowest, because of the NO consumption there and in the blood vessels at S4 .
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Figure 2.3. NO concentration as a function of height above crypt base (z) for baseline model.
Axial concentration variations are shown for radial positions r = 0, 18, and 32 [tm, which
correspond to the center of the luminal fluid, middle of the epithelium, and middle of the lamina
propria region, respectively. The calculations employed the baseline parameter values listed in
Tables 2.1 and 2.2.
2.3.2. Effect of NO Synthesis Rate of Epithelial Cells
Although the baseline rate of NO synthesis in epithelial cells is a conservatively high
value from cell lines in vitro, it is conceivable that the rate in vivo is much larger. Figure 2.4
shows results obtained by assuming that the rate of NO synthesis per unit volume in epithelial
cells equals the baseline rate for macrophages. The arrangement of the plot is the same as in
Figure 2.3. The maximum NO concentration in Figure 2.4 is 0.42 M, a 45% increase from that
under baseline conditions. However, the most notable difference from Figure 2.3 is the sigmoidal
shape of the concentration profiles for the luminal fluid and epithelium, leading to much higher
concentrations in the upper two-thirds of the crypt. The elevated concentrations in the upper part
of the crypt in Figure 2.4 reflect the fact that there is now a significant source of NO throughout
the crypt length.
2.3.3. Effect of Macrophage Spatial Distribution
In the baseline model, the main source of NO was assumed to be a confluent monolayer
of macrophages localized in the region below the crypt base, as suggested by
immunohistochemical stains of Citrobacter rodentium infection models in mice [Sohn, 2005].
However, similar staining of colons in other infection models in animals has shown macrophage
infiltration into the lamina propria as well [Berg et al, 1996; Leithauser et al, 2001].
Accordingly, additional scenarios were considered. In a second model, the macrophages were
assumed to be distributed homogeneously throughout regions V3, V4, and Vs; as there was no
longer a macrophage monolayer, these three regions were assigned identical properties. To
maintain the same total rate of macrophage NO synthesis, the source term was evaluated as
kV
k = 4 (2.12)
V3 + 4 V5
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Figure 2.4. NO concentration as a function of height above crypt base for a high rate of NO
synthesis in the epithelium. Axial concentration profiles are shown for the same radial positions
as in Figure 2.3. The NO synthesis rate per unit volume in epithelial cells was assumed here to
be 5.6 jM/s, the same as the baseline rate for macrophages.
where kg is the rate assigned in the new model to volumes V3 through Vs, and k9 is the baseline
rate for V4. In a third model, there was both a macrophage monolayer in V4 and macrophages
distributed throughout V3 and Vs. In this composite model, it was assumed that the total number
of macrophages was twice that in either of the first two scenarios, thereby doubling the overall
rate of NO synthesis.
Concentration profiles for the three macrophage arrangements (monolayer, distributed,
and monolayer + distributed) are shown in Figure 2.5. Axial variations in NO concentration are
depicted once again, but now only for r = 0. In comparing the results for the monolayer
(baseline) and distributed models, the most striking difference is that the maximum concentration
in the latter is only 10% of that in the former. Distributing macrophages throughout the lamina
propria is seen to yield a much more uniform NO concentration than in the monolayer model,
and slightly higher values in the upper third of the crypt, but the concentrations never exceed
0.03 tM. This indicates that activated macrophages must be spatially concentrated to produce
high local concentrations of NO. The NO concentrations in the third (monolayer + distributed)
model are, of course, higher than in the other models, because of the increased total rate of
synthesis.
The point that macrophages must be co-localized to produce high NO concentrations is
further illustrated by calculations done for a simpler situation. In this case we supposed that a
spherical macrophage aggregate of radius R was surrounded by an indefinitely large volume of
lamina propria tissue. Equation 2.9 was applied to both the macrophage aggregate and the
surrounding tissue, with NO synthesis being confined to the former. The NO concentration far
from the aggregate was assumed to vanish, due to outward diffusion and to consumption in the
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Figure 2.5. NO concentration as a function of height above crypt base for various spatial
distributions of macrophages. All results here are for the center of the luminal fluid (r = 0). The
"monolayer" model used the baseline parameter values; the "distributed" model had no
macrophage monolayer and assumed a rate of NO synthesis in the lamina propria regions of k=
0.8 tM/s; the "monolayer + distributed" model assumed that k = 5.6 gM/s and k9 = 0.9 M/s
for the macrophage monolayer and lamina propria regions, respectively.
lamina propria cells. An analytical expression was derived for the NO concentration as a
function of the radial distance from the aggregate center (r), as given in Appendix A.
Results based on the macrophage aggregate model are shown in Figure 2.6, which depicts
concentration profiles for R = 7.5, 15, and 22.5 tm. For an isolated macrophage (R = 7.5 jtm),
the maximum NO concentration (at the cell center) was only 0.07 tM for the synthesis rates we
employed (Table 2.2). Doubling the aggregate radius (corresponding to 8 tightly packed cells)
more than tripled the maximum concentration, to 0.26 M. Tripling the aggregate radius
(corresponding to 27 cells) increased the maximum concentration further, to 0.55 pM. Although
higher concentrations might be obtained in theory, there are practical limits on the sizes of
hypothetical macrophage aggregates. In our crypt model, for instance, the radius of such an
aggregate could not exceed 25 jm, the thickness of the lamina propria region. In addition to
limitations in aggregate size, other factors would mitigate against further increases in NO
concentration. That is, the larger an aggregate, the more likely it is to be near a blood vessel that
is a sink for NO. Moreover, the larger an aggregate, the more prominent is NO consumption
relative to diffusion, all other factors being equal. Overall, with synthesis rates as measured in
RAW264.7 cells, tissue NO concentrations greater than about 1 ViM seem very unlikely, no
matter how the macrophages are distributed.
2.3.4. Effect of NO Synthesis Rate of Macrophages
The macrophage NO synthesis rate used in the baseline model (kg , Table 2.2) is that
measured for murine macrophage-like RAW264.7 cells, which have been shown to synthesize
NO02 and NO3- at rates similar to those of primary macrophages [Stuehr and Marletta, 1987].
Nevertheless, there is uncertainty in the NO generation rate of macrophages in vivo. The effect
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Figure 2.6. Radial NO concentration profiles for hypothetical macrophage aggregates
surrounded by lamina propria tissue. Results are shown for macrophage aggregates with radii of
7.5, 15 and 22.5 tm. The calculations were based on macrophage synthesis and cellular
consumption rates of k = 5.6 tM/s and kc = 0.6 s-, respectively.g
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of varying the macrophage NO synthesis rate was simulated for three different cases: the
macrophage monolayer (baseline) model, the "monolayer + distributed" model introduced in
Figure 2.5, and a scenario in which there is also epithelial synthesis at the same volumetric rate
as in the macrophages. In this third case, termed the "monolayer + distributed + epithelium"
model, there are three crypt regions synthesizing significant amounts of NO: a layer of
macrophages at the crypt base, macrophages distributed in the lamina propria regions, and the
epithelial cells.
Figure 2.7 shows maximum NO concentrations in the crypt for each of the three models
just described, as a function of the NO synthesis rate. In each case the maximum NO
concentration increases linearly with the rate of NO synthesis, which is a consequence of having
a linear differential equation with one source term (a in Eq. 2.9) in each region. The
macrophage NO synthesis rate in Table 2.2 (kg = 5.6 M/s) results in maximum NO
concentrations of 0.29 [tM, 0.35 [tM, 0.48 tM, respectively, in the three models. For the NO
concentration to exceed 1.0 pM in each of the models, the NO synthesis rates by macrophages
must be greater than approximately 20 jM/s, 16 tM/s, and 12 pM/s, respectively. We conclude
that, even if tissue macrophages synthesize NO at twice the rate measured with RAW264.7 cells,
NO concentrations in the crypt will remain sub-micromolar.
2.3.5. Microvascular Assumptions
The sensitivity of the results to assumptions made about the surrounding blood vessels
was examined by comparing the maximum NO concentrations in the epithelium for five
situations, as shown in Figure 2.8. Case 1 is the baseline model. In Case 2, the concentrations at
S4 and S5 were specified as 50 nM (maximum concentration estimated at outside of blood vessels
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Figure 2.7. Effect of macrophage NO synthesis rate on maximum epithelial NO concentrations
for the monolayer (baseline), monolayer + distributed, and monolayer + distributed + epithelium
models. The calculations assumed k = k9 in the monolayer + distributed model and k = k =
k9 in the monolayer + distributed + epithelium model.
[Lamkin-Kennard et al, 2004]), rather than zero. In Case 3, Eq. 2.7 was replaced at surface S5 by
a no-flux boundary condition. This is equivalent to assuming that NO diffusing into the
muscularis mucosa encounters a significant resistance (perhaps because the distance LT is larger
than we assumed), and consequently that boundary no longer acts as a sink for NO. In Case 4,
R3 was shortened from 45 to 30 pm, reducing the distance from the epithelial cells to the
capillaries from 25 to 10 tm. (It seems unlikely that distance is significantly larger than the
baseline value, given that epithelial cells have been reported to be no more than 30 Jtm from
blood vessels in rats [Mohiuddin, 1996]). Case 5 is a composite of the preceding two, with both
a no-flux boundary condition at the bottom and capillaries closer to the epithelium.
As seen in Figure 2.8, relaxing the assumption that the NO concentration in blood is zero
(Case 2) resulted in a 29% increase in the maximum epithelial NO concentration, relative to the
baseline model (Case 1). Eliminating the downward diffusion of NO to S5 (Case 3) produced a
larger (40%) increase, by removing that vascular sink. In contrast, moving the crypt capillaries
closer to the epithelium (Case 4) lowered the maximum NO concentration (by 33%), by reducing
the resistance to diffusion toward that other sink. Combining the latter two effects (Case 5) gave
a result much like that of just repositioning the capillaries, suggesting that the value of R3 is more
crucial than is the boundary condition at the bottom. Overall, we conclude that the results are
not highly sensitive to the various simplifications made in representing the microvasculature.
2.4. Discussion
We developed a novel computational model to describe the interplay among the
synthesis, consumption, and diffusion of NO in a colonic crypt, and used it to estimate spatially
varying NO concentrations during inflammation. Previous models have described NO generated
from idealized point sources [Lancaster, 1994; Wood and Garthwaite, 1994], NO diffusion from
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Figure 2.8: Maximum epithelial NO concentrations for several alternative assumptions
concerning the crypt microvasculature: Case 1, baseline; Case 2, non-zero (50 nM) NO
concentration in blood; Case 3 no-flux boundary condition at the bottom surface (S5); Case 4,
reduced radial distance to capillaries (R3 = 30 jtm); and Case 5, no-flux boundary condition at
bottom and R3 = 30 xm.
spherical neurons in the brain [Phillipides et al, 2000], and NO diffusion from endothelium into
surrounding tissue [Vaughn et al, 1998], but this appears to be the first attempt to estimate NO
concentrations in any specific, inflamed tissue. The focus here is on colonic crypts, but a similar
methodology could be applied to other regions of inflammation. Using known anatomical
dimensions and data on the cellular rates of NO synthesis and consumption in vitro, we
calculated a maximum concentration (near the base of the crypt) of 0.3 lM (Figure 2.3). The
results suggest that, under inflammatory conditions, the NO concentration is determined mainly
by synthesis in activated macrophages, with epithelial NO synthesis likely to be negligible. Even
if epithelial cells were assumed to synthesize NO at rates comparable to macrophages, the NO
concentrations in the crypt remained below 0.5 jM (Figure 2.4). Normal NO concentrations, in
the absence of inflammation, are unlikely to exceed 50 nM [Lampkin et al, 2004].
We found that, for a colonic crypt, the only important pathways for NO consumption are
intracellular reactions (such as with 02-, oxygen-ligated metals, and NO dioxygenases) and the
reaction with oxyhemoglobin in blood. The reaction of NO with extracellular 02 generated by
macrophages is expected to be localized to within about 1 pm of the cells, and the rate of 02-
production is too small for this to be a significant sink for NO [Chen and Deen, 2002; Nalwaya
and Deen, 2005]. Likewise, the rate of autoxidation was shown to be negligible in a crypt. This
is a consequence mainly of the small length scale, and contrasts with the situation for
macrophages cultured on a flat plate covered with medium. The Damkihler number (y, Eq. 2.8)
that measures the importance of autoxidation relative to diffusion depends on the square of the
characteristic linear dimension. Thus, for a plate culture with a medium depth of 2 mm, yis some
400 times larger than in a crypt with a height of -0. 1 mm. Whereas autoxidation was found to
be an important factor in analyzing data from macrophage plate cultures [Chen and Deen, 2005]
[Chen and Deen, 2002], it could be safely neglected in the present analysis.
The 02 concentration distribution within a crypt might affect the NO concentration by
altering the rate of autoxidation, the rate of NO consumption by intracellular processes, the rate
of NO synthesis by iNOS, or some combination of these. As just discussed, autoxidation was
found to be a negligible sink for NO in this setting, and as mentioned earlier in connection with
Eq. 2.11, intracellular consumption was of only marginal importance. To assess whether or not
02 might become limiting in NO synthesis, we approximated the rate of 02 consumption as a
constant. The resulting dimensionless conservation equation for 02, analogous to Eq. 2.9 for
NO, was
V2 r - 4 = 0 (2.13)
S=kr (2.14)
Do2 02
where kr is the rate of 02 consumption and 3is the corresponding Damk6hler number. Using the
values listed in Tables 2.1 and 2.2, Sdid not exceed 0.17 in any region of the crypt, indicating
that the 02 concentration will be relatively uniform, as assumed. Indeed, the minimum 02
concentration calculated within the macrophage layer (V4) using Eqs. 2.13 and 2.14 was 37.8
M, or 94.5 % of the venous value. The Michaelis constant for oxygen-dependent production of
NO by iNOS has been reported to be around 6 jM; iNOS is the least O02-sensitive NOS isoform
at low pO2 [Rengasamy and Johns, 1996]. Although there is evidence that inflammatory bowel
disease is associated with increased oxygen metabolism and tissue hypoxia [Taylor and Colgan,
2007], to reach concentrations as low as 6 VM the rate of respiration would need to be
approximately 9.5 times the value of kr given in Table 2.2. Thus, it seems unlikely that 02
availability would be a significant factor in NO synthesis. With 02 apparently not limiting either
NO synthesis or NO consumption, NO concentrations could be calculated without evaluating
those for 02. This provided a valuable simplification in formulating the crypt model.
Simulations based on various spatial distributions of cells showed that macrophages
grouped closely together are necessary to elicit maximum NO concentrations as large as those
calculated in the baseline, monolayer model (Figure 2.5). This conclusion was reinforced by
results obtained from a simplified model, in which a spherical aggregate of macrophages was
assumed to be surrounded by tissue cells that do not synthesize NO. It was found that increasing
the radius of an aggregate of tightly packed cells markedly increased the maximum concentration
of NO, which occurred at the center (Figure 2.6). In reality, the size of any macrophage
aggregate will be limited by the physical dimensions of the crypt, and the maximum NO
concentration will be reduced by the proximity of the macrophages to blood vessels, which act as
NO sinks.
The effect of macrophage distribution on the maximum NO concentration may be helpful
in interpreting observations on the temporal progression of IBD. In mice, immunohistochemical
stains of colonic tissue taken two weeks after infection with Citrobacter rodentium depict
localization of macrophages below the crypt base (D.B. Schauer, unpublished observations).
However, one month after infection, the number of macrophages increases slightly and
macrophage infiltration is observed throughout the lamina propria. Thus the distribution and
number of macrophages in the inflamed mucosa may change over time. Our results indicate that
even if the number of macrophages increases somewhat, if the macrophages are dispersed
throughout the lamina propria, the maximum NO concentrations will be lower than in the
baseline scenario (macrophage monolayer). These results suggest that it is the earlier stage of
the disease which elicits the highest concentrations of NO and therefore inflicts the most damage
on cells.
Colonic epithelial cells originate at the crypt base and migrate to the crypt top over
several days. Assuming that this movement is undisturbed by inflammation, a given epithelial
cell will experience a wide range of NO concentrations during its lifetime, the concentration
decreasing as it ages and migrates upward. Given an NO concentration field computed using the
crypt model, and an assumed velocity vector for the cell (v), the instantaneous NO concentration
and the cumulative NO dose experienced by the cell at time t can be calculated as
Cc (t) = Co + - CNdt (2.15)
0
M (t)= Cc (t) dt (2.16)
0
In these expressions, Co is the initial NO concentration (the value at the base of the crypt), Cc (t)
is the concentration in an epithelial cell after it has migrated for a time t, and M(t) is its
cumulative dose of NO up to that instant ("area under the curve").
Figure 2.9 shows the NO concentration and dose history calculated from Eqs. 2.15 and
2.16 using results obtained with the baseline (macrophage monolayer) model or the "monolayer
+ distributed" model (introduced in connection with Figure 2.5). The migration time in each
case was assumed to be 4 days. The maximum NO concentration is experienced at t = 0, when
the epithelial cell is located at the base of the crypt. As the epithelial cell migrates away from the
macrophage layer, the concentration that it is exposed to decreases, whereas the cumulative dose
increases. By the time the epithelial cell has finished migrating at t = 96 hr, it has been exposed
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Figure 2.9. Time-dependent NO concentration and cumulative NO dose experienced by an
epithelial cell as it migrates from the crypt base to the mucosal surface. The total time for
migration was assumed to be 96 hr. Results are shown for the monolayer and monolayer +
distributed models.
to doses of 560 M-min and 940 tM-min in the monolayer and monolayer + distributed models,
respectively.
Is the NO exposure depicted in Figure 2.9 toxic? In studies involving carefully
controlled exposure to NO over 24 hr, toxicity thresholds for human lymphoblastoid (TK6) cells
were found to occur at an NO concentration of 0.5 tM and a dose of 150 iM-min [Thomas et al,
2001; Li et al, 2006]. Both of these thresholds (concentration and dose) had to be exceeded for
the number of viable cells to decline in a dose-dependent manner, relative to controls; if neither
or just one was exceeded, the cells proliferated normally. Other cell types, including p53-null
human lymphoblastoid (NH32), human colon cancer (HCT116), and melanoma cell (A375) lines
have been shown to be more resistant to NO [Li et al, 2006; Li et al, 2009]. Even if colonic
epithelial cells are as sensitive to NO as TK6 cells, the results in Figure 2.9 suggest that they will
remain viable, because even the maximum predicted concentration does not exceed the
corresponding threshold. Cell viability is, of course, a prerequisite for mutations leading to
oncogene activation or suppressor gene inactivation.
At sub-toxic concentrations comparable to those predicted by our baseline model, NO has
been shown to influence specific sets of signal transduction pathways. In breast cancer cells
(MCF7) it was found that at steady-state NO concentrations of 0.1 to 0.3 rM, hypoxic inducible
factor-l a (HIF-la) accumulates, and that p53 serine-15 phosphorylation occurs at NO
concentrations above 0.3 aM [Thomas et al, 2004]. HIF-l c is associated with tumor
proliferation and differentiation. When activated by phosphorylation, p53 regulates the cell
cycle through growth arrest or apoptosis; p53 inactivity results in a loss of this protective effect
and can lead to tumorigenesis [Thomas et al, 2004]. Thus, depending on concentration and
duration of exposure, NO may regulate signal transduction cascades in cancer cells with either
tumor-promoting or tumor-suppressing effects.
NO may also be linked to mutational events in the different cell populations within the
colonic crypt. In a healthy mucosa, proliferating epithelial cells are predominantly found in the
lower two-thirds of the crypt. However, in vitro labeling studies for patients with colitis showed
that DNA-synthesizing cells are located mainly in the upper third of the crypt, suggesting an
upward shift in the proliferation zone [Lipkin, 1974]. Thus, at the concentration and dose levels
predicted by our model, exposure to NO and related reactive nitrogen species may initiate a
mutagenic change in the population of migrating epithelial cells, allowing them to develop
irregular proliferative behavior and additional abnormal properties that enable them to be
retained in the mucosa. These dysplastic cells may expand laterally and downwards, eventually
displacing the normal crypt epithelium, as hypothesized in 'top-down' models of tumorigenesis
in the colon [Shih et al, 2001]. While mutational changes may occur in epithelial daughter cells,
it has also been argued that any genetic alteration will be lost in these cells as they will invariably
move out of the crypt [Potten and Lowffler, 1990]. Our model predicts that putative stem cells,
which remain at or near the base of the crypt, are exposed to the highest concentrations of NO. In
contrast to migrating epithelial cells, any oncogenic mutations in the stem cell population could
accumulate and persist over time. For instance, alterations in the stem cells could result in
dysplastic progeny, eventually giving rise to the formation of dysplastic crypts that continue to
divide as the lesions spread from the bottom of the crypt [Preston et al, 2003]. For either
scenario of tumorigenesis in the colonic crypts, our model can be used to estimate NO
concentrations at which possible mutational events may occur, irrespective of where these
genetic changes take place (at the top or the base of the crypt). Thus, although the molecular
biological linkage between NO exposure and carcinogenesis in IBD remains unclear, continuing
efforts to elucidate the underlying mechanisms should benefit from having estimates of NO
concentrations in inflamed crypts.
Chapter 3. Nitric Oxide, Oxygen, and Superoxide Formation and Consumption in
Macrophages and Colonic Epithelial Cells
3.1. Introduction
Chronic increases in the rates of endogenous synthesis of NO have been implicated in the
development of several human diseases, including cancer [Tamir and Tannenbaum, 1996]. In
the gastrointestinal tract, NO or its metabolites have been linked to the pathogenesis of
inflammatory bowel diseases (IBD), which often precede colon cancer [Levin, 1993; Farrell and
Peppercorn, 2002] . Immunohistochemical staining of samples from patients with active
ulcerative colitis show that significant inducible nitric oxide synthase (iNOS) activity is localized
in the crypt epithelium and in macrophages aggregated around crypt abscesses [Singer et al.,
1996; Kimura, et al., 1998]. However, it remains unknown what concentrations of NO in the
colon are pathophysiological. The rates at which macrophages and epithelial cells synthesize
NO is critical for predicting NO concentrations in a colonic crypt during inflammation [Chin, et
al., 2008], and the levels of NO are needed to estimate the intracellular concentrations of other
reactive nitrogen species [Lim, et al., 2008]. Thus, a knowledge of the synthetic capacities of
macrophages and epithelial cells is needed to improve the design of experiments to probe the
cytotoxic and mutatgenic effects of NO, and thereby clarify the mechanisms by which NO
exposure is linked to carcinogenesis in IBD.
Two strategies have been used previously to measure cellular rates of NO production.
Usually, the rate of NO synthesis is inferred from the rates of accumulation of stable end
products of NO oxidation [Wiffhoft, et al., 1998; Wright, et al., 1999; Chen and Deen, 2002]. In
a typical plate culture system (Figure 3.1), NO produced by cells will experience one of four
principal fates: consumption by cells, reaction with 02 in the media to form NO2-, reaction with
Figure 3.1. The three major fates of NO generated by cells in a typical plate culture experiment:
diffusion through the media to the headspace, oxidation to NO2- via Reaction 1, or oxidation to
NOj3 via Reaction 2.
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02- in the media to form NO3-, or escape to the headspace by diffusion. The relatively slow,
multistep reaction with 02, termed autoxidation, is written overall as [Lewis and Deen, 1994].
4NO + 0 2 - 2N 20 3  +2H20 > 4NO-+4H + . (3.1)
The very fast reaction of NO with 02 is [Ischiropoulos, et al., 1992; Huie and Padmaja, 1993]
NO + 02 -- ONOO- co > NO . (3.2)
As indicated, the rearrangement of peroxynitrite (ONOO-) to NO3- is catalyzed by CO2 [Lymar
and Hurst, 1996]. In an open system, the extent to which the diffusional loss of NO competes
with Reactions 3.1 and 3.2 is determined by the liquid depth and the availability of 02 and 02 in
the medium. Extracellular 02 is synthesized by macrophages via a membrane-bound NADPH
oxidase [Babior, 1984; Berton, et al., 1988], and may also be generated photochemically in
culture media [Keynes, et al., 2003]. The fraction of the NO lost to the headspace can be
significant, so that using NO2- and NO3- accumulation rates without correcting for NO loss can
greatly underestimate NO production rates [Chen and Deen, 2001]. The second strategy is to
continuously monitor NO and 02 concentrations in a closed chamber [Nalwaya and Deen, 2005].
There is no physical loss of NO in this case, but extracellular Reactions 3.1 and 3.2 still must be
considered when calculating cellular rates of NO synthesis. With either approach, separate
experiments are needed to quantify extracellular 02-production, and the cellular consumption
rate for 02 also must be measured or estimated to obtain reliable results.
Another consideration in measuring rates of NO synthesis is that cells also consume NO.
Reaction 3.2 is fast enough to allow NO to compete with superoxide dismutase for 02 [Nalwaya
and Deen, 2003], so that it will occur to some extent in virtually all cells. Other pathways for
intracellular consumption of NO involve nitrogen dioxygenases [Gardner, et al., 2000] and
reactions with oxygen-ligated reduced metals [Eich, et al., 1996]. Each of these reaction
pathways involves NO oxidation to NO3-, so a 1:1 stoichiometry can be assumed for 02 usage in
the intracellular consumption of NO. In NO-producing cells the net rate is the difference
between the rates of synthesis and consumption, whereas in other cells there will be consumption
only. This motivates experiments to measure NO consumption rates.
Reported here are rates of formation and consumption of NO, O2, and 02 for
macrophage-like RAW264.7 cells, primary bone marrow-derived macrophages (BMDM), and
HCT116 colonic epithelial cells under simulated inflammatory conditions. A combination of
open-system and closed-system experiments was used to determine the rates of NO synthesis.
With the former, a diffusion-reaction model was used to correct for NO losses to the headspace,
and with the latter a batch reactor model was used to account for the various NO consumption
pathways. Cellular rates of 02 consumption, NO consumption, and O2- production were
measured in separate experiments. The open-system method with loss corrections and the more
direct closed-system method have both been applied previously to RAW264.7 cells [Nalwaya
and Deen, 2005], but not to BMDM or HCT116 cells. Inflammatory conditions were simulated
either by the addition of cytokines or by infection with Helicobacter cinaedi. H. cinaedi
colonizes the lower bowel of various hosts, inducing intestinal inflammation with a pathology
similar to that in human IBD, and has been found to upregulate iNOS expression in the cecum of
mice [Shen, et al., 2009]. The NO synthetic capacity of HCT1 16 cells was tested also by
exposing them to resveratrol and capsaicin; resveratrol has been shown to increase NOS
expression in human adenoma carcinoma cells (SNU-1) [Holian, et al., 2002] and the injection of
capsaicin into Sprague Dawley rats was found to upregulate all three NOS isoforms in the
subnucleus caudalis [Lee, et al., 2008]. The cellular kinetic results were combined with a
previously described model for NO diffusion and reaction in colonic crypts [Chin, et al., 2008] to
provide improved estimates of NO concentrations in inflamed crypts.
3.2. Experimental Methods
3.2.1. Mammalian Cell Culture
Cells of the mouse macrophage-like RAW264.7 line (ATCC No. TIB-71), obtained from
the American Type Culture Collection (Rockville, MD), were cultured in Dulbecco's modified
Eagle's medium (DMEM) containing L-glutamine supplemented with 100 U/mL penicillin, 100
[tg/mL streptomycin, and 10% (v/v) heat-inactivated fetal bovine serum (FBS) (BioWhittaker,
Walkersville, MD). Cells of the human colon cancer HCT116 line (ATCC No. CCL-247,
courtesy of G. N. Wogan, Department of Biological Engineering, MIT) were cultured in
McCoy's 5A medium (BioWhittaker, Walkersville, MD) and supplemented with 10% heat-
inactivated FBS and one per cent each of 100 U/mL penicillin and 100 [tg/mL streptomycin. All
cells were maintained at 37 'C in a humidified 5% CO2 atmosphere.
3.2.2. Growth of Helicobacter cinaedi
H. cinaedi, obtained from the Culture Collection, University of Giteborg, Sweden
(CCUG 18818),were plated from freezing stock onto blood agar plates (Remel, Lenexa, KS).
Bacteria were maintained in microaerobic chambers that were evacuated to -20 mm Hg and then
equilibrated with a gas mixture consisting of 80% N2 , 10% H2, and 10% CO2. After 72 hr,
bacteria were gently loosened from the plate, transferred to a shaker flask containing 20 mL of
Brucella broth (BD Diagnostics, Franklin Lakes, NJ) with 10% FBS, and grown to log-phase.
The concentration of H. cinaedi was determined by optical density measurements. Bacterial
suspensions were centrifuged at 3000 g for 10 min and resuspended in antibiotic-free McCoy's
media with 10% FBS. Cells cultured in antibiotic-free media for at least one week were infected
by adding 1 mL of appropriately concentrated bacterial suspensions (see below).
Killed bacteria were prepared by treating the H. cinaedi (grown as described above) with
0.5% formalin for 24 h and storing them at 4oC. On the day of the experiment, the formalin-
killed bacteria were washed three times with PBS and resuspended in antibiotic-free McCoy's
media with 10% FBS.
3.2.3. Isolation of Primary Macrophages
Primary bone-marrow-derived macrophages (BMDM) were isolated from mice as
described in Tomczak et al. (2003). Approximately 98% of the cultured cells obtained by this
method are macrophages, as assessed by flow cytometry. Briefly, BMDM were obtained from
C57/B16 mice (Jackson Laboratories, Bar Harbor, ME), two to four months old. After flushing
the femurs with cell culture media, single-cell suspensions were incubated on tissue culture
plates in bone marrow macrophage medium, consisting of DMEM with 10% fetal bovine serum,
5% horse serum, penicillin 100 U/mL, streptomycin 100 [tg/mL, 2 mM L-glutamine, and 10% L
cell-conditioned medium. Macrophages were cultured for 5 days before use in experiments and
were removed from plates by scraping.
3.2.4. Materials
Additional reagents used include recombinant mouse IFN-y from R&D Systems
(Minneapolis, MN) as well as recombinant human IFN-y and TNF-a from Invitrogen (Camarillo,
CA). Escherichia coli lipopolysaccharide (LPS), bovine erythrocyte superoxide dismutase
(SOD), capsaicin, resveratrol, rotenone, cytochrome c from horse heart, HEPES buffer solution
(pH 7.4), and trypan blue (4% in saline) were all from Sigma Aldrich (St. Louis, MO). N-
methyl-L-arginine monoacetate (NMA) was from CalBiochem Research (Salt Lake City, UT),
and beef liver catalase was from Roche Molecular Biochemicals (Indianapolis, IN).
3.2.5. Closed Chamber for Measurement of NO and 02 Concentrations
The apparatus shown in Figure 3.2, similar to that described in Nalwaya and Deen
(2005), was used to continuously monitor NO and 02 concentrations. A polycarbonate insert
equipped with a stirring motor (Instech Laboratories, Plymouth Meeting, PA), NO electrode
(World Precision Instruments, Sarasota, FL), and fiberoptic 02 sensor (Instech Laboratories,
Plymouth Meeting, PA) was machined to fit within standard 60 mm polystyrene tissue culture
dishes. After assembly, the chamber had a total liquid volume of 8.8 mL. All measurements
were conducted in a 370 C warm room in the dark, to eliminate NO consumption by light-
sensitive riboflavin-derived 02- in the medium.
3.2.6. 02 Consumption by Unactivated Cells in Closed Chamber
Cells (RAW264.7, BMDM, or HCT116) were detached from stock plates and
resuspended in media into a homogeneous suspension through vigorous pipetting. The number
of viable cells was determined by trypan blue exclusion. Between 5 x 106 and 8 x 106 cells were
plated on 60 mm dishes and allowed to adhere for 2-3 h. To begin an experiment, the medium in
a given dish was replaced with 15 mL of DMEM with 25 mM HEPES preheated to 37 'C and
the dish was assembled with the closed-chamber insert. The 02 concentration was then
monitored for 20-30 min and the rate of consumption calculated from the slope of the curve.
magnetic stir motor
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Figure 3.2. Schematic of apparatus used to measure NO and 02 concentrations in culture media.
The polycarbonate insert formed an air-tight seal with a 60 mm tissue culture dish, with adherent
cells on the bottom. The enclosed liquid volume was 8.8 mL.
3.2.7. NO Synthesis and 02 and NO Consumption by Activated Cells in Closed Chamber
Between 5 x 106 and 8 x 106 cells were seeded onto 60 mm dishes. After the cells were
allowed to adhere for 2-3 h, the media in plates containing RAW264.7 or BMDM was replaced
with fresh DMEM containing LPS (20 ng/mL) and IFN-y (20 U/mL); HCT116 cultures were
replenished with McCoy's media containing capsaicin (100 1.M) and resveratrol (50 tM).
Because it takes -6-8 h after the addition of LPS and IFN-7 for macrophages to produce NO
[Lewis, et al., 1995], the concentration measurements to determine rates of NO production and
consumption for RAW264.7 and BMDM were performed after 12 h. Experiments with HCT116
cells were performed at 24 h after the addition of capsaicin and resveratrol. At the start of each
experiment, fresh, preheated media with 25 mM HEPES was added to the dish and the apparatus
was sealed. The NO and 02 concentrations were monitored until a steady NO concentration was
achieved, typically 15-20 min. Calculations were done using the kinetic model described below.
02 concentrations were also monitored for activated RAW264.7 cells in the presence of
rotenone, a respiratory inhibitor. After the 12 h stimulation with IFN-y and LPS, 2 liM of
rotenone was added to the media and cells were exposed to the respiratory inhibitor for 1h.
3.2.8. NO Synthesis in Open System
To avoid bacterial contamination of the NO electrode, rates of NO synthesis by
RAW264.7 or HCT116 cells infected with H. cinaedi were assessed by measuring concentrations
of NO2- and NO3- as a function of time in an open system. The number of viable cells was
determined by trypan blue exclusion and cells were seeded at concentrations of I x 106 cells/well
into 6-well plates. RAW264.7 cells were infected by adding 1 mL of H. cinaedi suspension
containing either 2 x 107 cells/mL or 2 x 108 cells/mL to each well, giving a multiplicity of
infection (MOI, the ratio of bacteria number to mammalian cell number) of 10 or 100,
respectively. HCT116 cells were subjected to a pre-treatment of TNF-a (50 ng/mL) and of IFN-
y (100 U/mL) for 24 h prior to infection, and then were infected using the same procedure with
either live or killed H. cinaedi. The concentration of killed bacteria corresponded to an MOI of
100. Bacteria-free media was added to the control cells (total liquid volume of 2 mL/well).
Supernatant samples (1 sample per well) were collected at 24 and 48 h after infection and
centrifuged at 12,000 rpm before analysis. Nitrite and nitrate accumulation was quantified using
a Griess assay kit (R&D Systems, Minneapolis, MN). Briefly, 50 tL of culture supernatant was
allowed to react with 100 [tL of Griess reagent and incubated at room temperature for 10-30 min.
For measurement of N03-, NADH and nitrate reductase were added before reaction with the
Griess reagents. Absorbance was measured at 540 nm using a microplate reader.
Nitrite and nitrate production was also measured for BMDM and RAW264.7 cells
activated with IFN-y (20 U/mL) and LPS (20 ng/mL). This allowed NO production rates in the
open system to be compared with those in the closed chamber. Between 2 x 10' and 4 x 10S
macrophages were seeded into each well of a 24-well plate with or without IFN-y and LPS (total
liquid volume of 1 mL/well) and supernatant samples were collected at 0, 4, 8, 12, 24, 36, 48, 60,
and 72 hr for Griess analysis.
3.2.9. Superoxide Synthesis
Net cellular 02 synthesis of activated and unactivated macrophages was quantified using
a cytochrome c assay. After seeding macrophages (RAW264.7 or BMDM) into 24-well plates as
described above, 1 mL of media with or without IFN-y (20 U/mL), LPS (20 ng/mL) was added
to each well. NMA (2 mM), an iNOS inhibitor, was added to wells containing macrophages
stimulated with IFN-y and LPS because NO competes very effectively with ferricytochrome c for
02- [Deen, et al., 2002]. After stimulation of the macrophages with IFN-y and LPS for 4 or 8 h,
cytochrome c solution (80 [tM) was added to the cell supernatant and the mixture was
centrifuged at 4000 g for 1 minute. Absorbance at 550 nm was measured on 0.5 mL samples and
converted to nanomoles of ferrocytochrome c concentrations using the molar extinction
coefficient for the reduction of cytochrome c with ascorbic acid (21.0 x 103 M - 1 cm'- [Massey, et
al., 1959]). Plots of nanomoles of ferrocytochrome c vs. time were fitted linearly. The
difference in the slopes between samples incubated with SOD (1000 U/mL) and without SOD
was used to calculate the SOD-inhibitable 02- production rates for activated and unactivated cells
(ks and ks, respectively).
3.2.10. Model for Closed Chamber
The closed chamber in Figure 3.2 was modeled as a well-stirred batch reactor, as
described previously [Nalwaya and Deen, 2005]. The variation in NO concentration (CNO) with
time (t) was given by
dCo - m(kg -vkCuo- - 4k4,CNO2 0 -k, (3.1)
dt V
where m is the number of viable cells, V is the liquid volume, v is the volume of a single cell,
(modeled as a hemisphere with radius = 7.5 tm), ks is the rate of extracellular NO consumption
by macrophage-generated 02 (which equals the cellular rate of 02- synthesis), ka is the rate
constant for autoxidation of NO, and k,, is the rate of extracellular NO consumption by culture
medium-generated 02-. The values used for V, v, ka, and km are given in Table 3.1. Separate
experiments (described above) yielded ks. The kinetic parameters for NO that were evaluated
Table 3.1. Parameters used in the kinetic model for the closed chamber apparatus and in the
reaction-diffusion model for the open system
Value
8.8 x 10-3 L
8.8 x 10-13 L
1.77 x 10-10 m 2
2.6 x 106 M -2 S- 1
0.4 x 10-9 M s- 1
7 x 10-6 M
18 x 10-9 M
3.0 x 10-5 cm 2 S-1
2.8 x 10-5 cm 2 S- 1
223 puM
ReferenceParameter
V
v
a
ka
km,
KM
Ki
DNO
Co
Symbols: V, liquid volume in the closed chamber; v, volume of a single cell; a, area of a flat
surface occupied by a single cell; ka, rate constant for autoxidation of NO; k,,, rate of NO
consumption by media-generated 02-; KM, the 02 concentration at which respiration is halved in
the absence of NO; Ki, constant describing inhibition of respiration by NO; DNO and Do,
aqueous diffusivities of NO and 02 respectively; Co, liquid-phase 02 concentration in equilibrium
with the incubator.
see text
see text
see text
[Lewis and Deen, 1994]
[Nalwaya and Deen, 2005]
[Nalwaya and Deen, 2005]
[Nalwaya and Deen, 2005]
[Zacharia and Deen, 2004]
[Goldstick and Fatt, 1970]
[Chen and Deen, 2002]
from the closed-chamber experiments were kg, the rate of generation of NO, and kc, the rate
constant for intracellular consumption of NO.
The 02 concentration was described by:
dC m Rmax C2S- 2k + vkc CNo + (3.2)
dt V Co2 +KM (1+ CNo / KI )
The bracketed quantity is the rate of 02 consumption per cell. The first term is the rate at which
02 is consumed by iNOS in synthesizing NO, assuming a 2:1 stoichiometry [Stuehr, 1999], and
the second term is the rate of 02 usage during intracellular consumption of NO, with a 1:1
stoichiometry as discussed earlier. In the third term, which corresponds to 02 consumption from
respiration, R,,,,ax is the maximum rate, KM is the 02 concentration at which respiration is halved
(in the absence of NO), and KI accounts for the inhibition of respiration by NO [Brown, 1999].
The one 02 parameter obtained from the closed-chamber experiments was R,,,,ax. The values of
KM and K1 used (Table 3.1) were those determined previously from data for RAW264.7 cells
[Nalwaya and Deen, 2005]. Because they are intrinsic properties of the respiratory enzymes,
they were assumed to be the same for all cells (macrophages and epithelial). In applying
Equations 3.3 and 3.4 to NO and 02 measurements for HCT116 cells, the radius of a single cell
was assumed to be the same as that for macrophages [Galle, et al., 2009; Swietach, et al., 2009].
The ks term was omitted because epithelial cells do not synthesize 2- extracellularly (discussed
later).
The NO and 02 kinetic parameters (kg, ke, and R,,,ax) were calculated by fitting the NO
and 02 concentration data for RAW264.7, BMDM, and HCT 116 cells from appropriate sets of
experiments; the root-mean-square-difference between the measured concentrations and those
predicted by Equations 3.3 and 3.4 was minimized using the simplex method in MATLAB
(MathWorks, Natick, MA).
3.2.11. Model for Open System
In the open-system experiments the rate of accumulation of NO2 was used to infer
cellular rates of NO production for macrophages and epithelial cells. A model like that
previously described [Chen and Deen, 2001; Nalwaya and Deen, 2004] was used to account for
extracellular reactions, rates of diffusion, and the effects of liquid depth. Because the duration of
these experiments was long enough to achieve steady-state levels of NO and 02, the
concentrations were assumed to depend only on height within the liquid (z). In this model the
bottom of the well and the gas-liquid interface correspond to z = 0 and z = L, respectively. The
NO concentration in the liquid is governed by
d2Co 2dzo = 4ka C2 NO, + k (3.3)
dCN () - NNo (1- ) (3.4)
dz DNuo
NNO =[ k, -vkCCNo(0)] (3.5)
CNO (L) = 0 (3.6)
The parameters not already defined are: DNO, the diffusivity of NO in water (Table 3.1); a, the
fraction of the plate area covered by cells (based on the initial number of cells seeded into a
well); /, the ratio of the 02- to the NO flux; and NNO, the rate of NO release per unit area from a
hypothetical confluent monolayer of cells (units of mol m-2 s-1). The cellular flux of NO is
equivalent to the net rate of NO synthesis per cell divided by the planar area per cell (a = M2
with r = 7.5 jm). The NO consumption rate from media-generated 02- (k,,) was assumed to be
the same as that used in the closed chamber model (Table 3.1). The value of km is determined
largely by exposure of the culture medium to light [Nalwaya and Deen, 2005], which was
minimal in the open-system experiments and absent in the closed-chamber experiments.
The autoxidation reaction is too slow to have a significant effect on the 02 concentration
[Chen and Deen, 2002], which is given by
aN L
Co (z) C 1(3.7)
D 02
No 1 2k +vkCo +RmaxCo
N a 2Co2 + K, (1+CNo / K , ) (3.8)
Here, Co is the liquid-phase 02 concentration in equilibrium with the incubator (Table 3.1),
Do, is the diffusivity of 02 (Table 3.1), and No2 is the rate of 02 consumption per unit area for a
confluent monolayer (units of mol m-2 S-1). Similar to the closed chamber model, 02
consumption in Equation 3.9 includes consumption by iNOS, 02 usage during intracellular
consumption of NO, and competitive inhibition of respiration by NO. The other parameters are
as defined for the chamber model. The NO flux and kg are related by Equation 3.7 and kc and
Rmax were obtained from the closed-chamber experiments. Thus, the one unknown parameter in
this model was NNO.
Equation 3.5 (with Equations 3.6-10) was solved using a commercial finite element
package (COMSOL v.3.0, Stockholm, Sweden). Rates of NO2- accumulation were calculated by
numerically integrating the local rate of NO2 formation (given by 4kaoC2 ) over the entire
solution volume. The value of NNO was adjusted until the fractional difference between the
calculated and measured rates of NO2- accumulation was <10 -6
3.3. Results
3.3.1. Oxygen Consumption by Unactivated Cells
A representative plot of 02 concentration as a function of time for unactivated BMDM
cells in the closed chamber is shown in Figure 3.3. The linear decline implies that the rate of 02
consumption was constant over the range of concentrations examined. Nearly identical plots
were generated for unactivated RAW264.7 and HCT116 cells (Figures 3.4 and 3.5). In each of
these experiments NO was undetectable, so that respiratory inhibition was absent. The average
rates of 02 consumption calculated from the slopes of such plots for RAW264.7, BMDM, and
HCT116 cells were R,,max = 37.7 + 4.3, 30.2 ± 3.4 and 26.0 ± 6.8 pmol s-1 106 cells - ', respectively.
As indicated in Table 3.2, oxygen consumption rates for HCT116 cells were not statistically
different from those of BMDM, and Rax values for BMDM and RAW264.7 cells were also
statistically indistinguishable from one another.
3.3.2. NO Synthesis and 02 and NO Consumption by Activated Cells in Closed Chamber
Figure 3.6 shows NO concentrations in a typical closed-chamber experiment, begun 12 h
after stimulation (i.e. addition of IFN-y and LPS to the media). In this plot, t = 0 is the moment
the test chamber was fully assembled and readings were begun. As seen, there was an initial
increase in CNO that leveled off at 0.45 tM at -800 s. At early times (t < -200 s), when lower
concentrations of NO were present, the decline in 02 concentration was nearly linear. The initial
slope for 02 shown in Figure 3.6 is greater than that observed for unactivated cells (Figure 3.3)
and is reflected in the higher rates of oxygen consumption by activated cells (R,,ax, Table 3.2).
As NO concentrations increased, the inhibitory effects of NO on respiration were observed, the
rate of 02 consumption gradually decreasing. Similar plots were generated for NO and 02
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Figure 3.4. Respiration by unactivated RAW246.7 cells (12 x 106 cells). Shown is a plot of 02
concentration as a function of time for a representative closed-chamber experiment.
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Figure 3.5. Respiration by HCT116 colonic epithelial cells. Shown is a plot of 02 concentration
as a function of time for a representative closed-chamber experiment with 8 x 106 unactivated
HCT 116 cells.
measurements with RAW264.7 cells (Figure 3.7). As seen in Figure 3.6, the addition of
rotenone (2 kM), a respiratory inhibitor, to activated RAW264.7 cells significantly decreased the
rate of 02 consumption. Applying the kinetic model to the data from such experiments, we
calculated that kg = 2.3 + 0.6 pmol s-1 (106 cells) - 1, kc= 1.3 + 0.3 s-1, and Rmax = 58.8 + 17 (n = 6)
for activated BMDMs (Table 3.2), all of which were not statistically different from the same
kinetic parameters measured for RAW264.7 cells.
A representative plot of NO and 02 concentrations for HCT1 16 cells measured 24 h after
incubation with capsaicin and resveratrol is shown in Figure 3.8. Similar to the experiments with
macrophages, a steady NO concentration was reached -800 s after the experiment started, the
value in this case being 0.16 tM. Again, inhibition of respiration by NO was observed in the
plot of C0g versus time. Applying the kinetic model, kg = 1.1 + 0. pmol s-1 (106 cells) -', kc= 4.1
± 2.3 s-1, and R,,ax= 40.8 ± 11.4 (n = 6) for activated HCT116 cells. For the HCT116 cells kg
was lower and kc was higher than for macrophages (p < 0.05).
3.3.3. Nitrite and Nitrate Accumulation for Activated Cells
Figure 3.9 shows NO2- and NO3- concentrations measured for HCT116 cells pretreated
with TNF-a (50 ng/mL) and IFN-y (100 U/mL) and infected with live H. cinaedi bacteria. In
this plot, 24 and 48 h correspond to the length of time that the cells were exposed to H. cinaedi.
The NO3- concentrations in all samples remained nearly constant and were statistically
indistinguishable from those detected in media alone. Likewise, uninfected cells and HCT 116
infected with H. cinaedi at MOI = 10 yielded NO2- concentrations which were not different from
those in the absence of cells. In contrast, a 4-fold increase in NO2- concentrations was measured
after 24 h for HCT116 cells infected with H. cinaedi at MOI = 100, 18.5 ± 1.0 [M as compared
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Figure 3.6. Measurement of NO synthesis, NO consumption, and 02 consumption by activated
primary macrophages (BMDM). After activation by 12 h exposure to IFN- and LPS, 8 x 106
cells were placed in the closed chamber at t = 0. As seen in this representative plot of NO and 02
concentrations, the rate of 02 consumption slowed as the NO concentration increased. The
kinetics of NO synthesis and consumption are reflected in the plateau concentration for NO and
the rate at which the plateau is reached.
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Figure 3.7. Representative plot of NO and 02 concentrations for activated RAW264.7 cells in
closed chamber experiments (8 x 106 cells), as described for BMDMs. 02 concentrations were
also monitored for activated RAW264.7 cells (9 X 106 cells) after a 1 h exposure to 2 M
rotenone, a respiratory inhibitory.
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Figure 3.8. Measurement of NO synthesis, NO consumption, and 02 consumption by activated
HCT116 cells stimulated with capsaicin and resveratrol. Results are shown for 7 x 106 cells in
the closed chamber. Induction of NO synthesis, as reflected by the increasing NO concentration,
inhibited respiration in a manner similar to that seen with macrophages in Figures 3.4 and 3.5.
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Table 3.2. Cellular kinetic parameters for NO, 02, and 02 measured in the closed-chamber
experiments.
Kinetic Parameter
Rmnax0 (pmol s-1 106 cells -')
Rmax (pmol s-1 106 cells -')
k, (pmol s-' 106 cells - 1)
kc (s -1)
k, (pmol s-1 106 cells -1)
k, (pmol s-1 106 cells -l)
RAW264.7
37.7 ± 4.3 (n = 4)
61.9 a 14 (n = 6)
2.1 ± 0.3 (n = 6)
1.6 ± 0.4 (n = 6)
0.07 ± 0.02 (n = 4)
0.3 ± 0.09 (n = 4)
BMDM
30.2 ± 3.4 (n = 4)
58.8 ± 16.7 (n = 6)
2.3 ± 0.6 (n = 6)
1.3 ± 0.3 (n = 6)
0.05 ± 0.01(n = 4)
0.3 ± 0.08 (n = 4)
HCT116
26.0 ± 6.8 (n = 4)t
40.8 ± 11.4 (n = 6)
1.1 +_ 0.2 (n = 6) tt
4.1 ± 2.3 (n = 6) t*
Symbols: Rmaxo and Rmax, maximum respiration rates for unactivated and activated cells,
respectively; kg, rate of generation of NO; kc, rate constant for intracellular consumption of NO
for activated cells; ks0 and ks, rates of extracellular 02- generation by unactivated and activated
macrophages, respectively. All values are mean ± SD for the number of experiments indicated.
tp < 0.05 versus RAW264.7 values, t p < 0.05 versus BMDM values.
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to 4.7 ± 0.6 tM for uninfected cells. The rate of NO2- accumulation for MOI = 100 was lower
for 24-48 h than for 0-24 h, probably due to a reduced number of viable cells. Experiments in
which HCT116 cells were exposed in the same manner to killed bacteria did not result in NOz
accumulation. Moreover, Griess assays on suspensions containing only H. cinaedi at
concentrations corresponding to MOI = 10 or 100 were negative, indicating that the bacteria
were not the source of N02- accumulation in the media.
Figure 3.10 shows NO2- accumulation for RAW264.7 cells infected with H. cinaedi for
24 h at MOI = 10 or 100. The 24 h data for infected HCT116 cells are shown again for
comparison. The NO2- concentrations measured for RAW264.7 cells infected at MOI = 100
(20.1 ± 2.7 tM and 27.7 ± 1.9 [tM for samples collected at 24 and 48 h, respectively) were not
statistically different from those measured for HCTI 16 cells. However, unlike HCT116 cells,
which were unresponsive to H.Cinaedi infections at MOI = 10, samples collected from infected
RAW264.7 cells showed increased NO2- accumulation after 48 h (17.0 ± 3.0 tM) when
compared to uninfected cells (5.1 ± 0.7 [tM).
The NO2- concentrations measured 24 h after infection with H. cinaedi at MOI = 100
were used to infer rates of NO production for macrophages and epithelial cells, using the open-
system model. NO synthesis rates for HCT1 16 cells and RAW264.7 cells were found to be 3.9 +
0.1 and 2.6 ± 0.1 pmol s-1 106 cells -1, respectively (Table 3.3). Thus, under these conditions, the
rate of NO synthesis of HCT1 16 cells was 50% higher than that of RAW264.7 cells.
Similarly, rates of NO synthesis were calculated from NO2- accumulation data for
BMDM and RAW264.7 cells stimulated with IFN-y and LPS. After 8 h, NO2- and NO3
concentrations increased continuously and were approximately linear in time for t = 8 - 48 h (see
3- 25
C
20 -
0
4--r 2
Media Control MOI 10MOI 100Control MOI 10MOI 100
I I I I
24 48
time (hr)
Figure 3.9. Nitrite and nitrate concentrations in the supernatant of HCT116 cells which were
infected with H. cinaedi. Means ± SD are shown for n = 5. The initial cell numbers were 1 x 106
for HCT116 and 1 x 107 or 1 X I08 for H. cinaedi, yielding multiplicity of infections (MOI) of 10
or 100. The times (24 or 48 h) correspond to the duration of exposure to the bacteria. The
increased NO2f concentrations for MOl = 100 are evidence of NO synthesis by the HCT116
cells.
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Figure 3.10. Comparison of NO2- concentrations for RAW264.7 cells and HCT116 cells
infected with H. cinaedi. Means ± SD are shown for n = 5. See Figure 3.7 for additional
explanation.
Table 3.3. Conditions and measured rates of NO synthesis for the open-system experiments.
Parameter RAW264.7 BMDM HCT 116 RAW264.7
Stimulant IFNy + LPS IFNy + LPS TNF-a + IFN-y, H. CinaediH. Cinaedi
a 0.35 0.2 0.2 0.2
1/ 0.15 0.15 0 0.15
L 5 mm 5 mm 2 mm 2 mm
Fraction NO lost 0.32 0.43 0.82 0.71
. pmol s(106 ell)- 2.5 ± 0.6 2.3 + 0.9 3.9 + 0.1 2.6 + 0.1kg. pmol s-' (106 cells) -)
(n = 2) (n =2) (n =5) (n =5)
Symbols: a, fraction of plate area covered by cells; fl, ratio of 02- to NO flux at cells; L, liquid
depth; kg, rate of NO generation by cells. Values for kg are mean ± SD.
Appendix C.10-11). The average slopes obtained by linear regression over that interval were
used to determine the accumulation rates of NO2-. The calculated rates of NO synthesis (kg) for
RAW264.7 cells in the open system were indistinguishable from those for BMDM (Table 3.3),
and the rates for either type of macrophage in the open system agreed with those in the closed
chamber (compare with Table 3.2).
3.3.4. Superoxide Synthesis
Figure 3.11 shows a representative plot of ferrocytochrome c concentration as a function
of time in experiments designed to measure rates of 02- synthesis for BMDM. Data are shown
for unactivated and activated BMDM as well as for culture medium alone (with and without
SOD present), with t = 0 being the time at which fresh medium with or without NMA, SOD,
LPS, and IFN-y was added. The linear increase in the concentration of ferrocytochrome c with
time indicates that 02- synthesis occurred at a constant rate throughout the 8 h period. Samples
containing SOD (either with unactivated cells, activated cells, or media alone) were
indistinguishable from one another and had significantly lower slopes of ferrocytochrome c vs.
time compared to samples without SOD. The difference in the slopes between experiments
conducted in the absence or presence of SOD was used to calculate the 02 production rates for
activated and unactivated macrophages (ks and ks) listed in Table 3.2. Similar results were
obtained for RAW264.7 cells (Figure 3.12). Unactivated macrophages yielded slopes that were
indistinguishable from those for medium alone, implying that little or no 02 is produced at their
outer membrane surface, which is consistent with previous work showing low NADPH oxidase
activity in untreated macrophages [Sasada, et al., 1983]. As shown in Table 3.2, the net cellular
superoxide synthesis rate is only 13% of the rate of NO synthesis by activated BMDM.
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Figure 3.11. Rate of 02 production by primary macrophages (BMDM). Plotted are nmol of
ferrocytochrome c detected as a function of time for representative experiments with 5 x 105 cells
and with culture medium only. Results are shown for cells activated by incubation with IFN-
y and LPS beginning at t= 0 in the absence or presence of SOD, unactivated cells, untreated
medium, and medium with SOD. The rate of cellular 02 production was calculated from the
difference in slopes between the data for activated or unactivated cells and that for medium with
SOD. The results for unactivated cells and untreated medium were nearly identical. The
addition of SOD eliminated most of the ferrocytochrome c formation associated with the media.
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Figure 3.12. Rate of 02- production by RAW264.7 cells. Plotted are nmol of ferrocytochrome c
detected as a function of time for representative experiments with 5 x 105 cells. The rate of
cellular 2Oz production was calculated from the difference in slopes between the data for
activated (with IFNy + LPS) or unactivated cells and that for medium with SOD (from Figure
3.9).
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Similar experiments to determine whether or not HCT116 cells are capable of producing
extracellular 02 were also conducted. Supernatant samples collected from HCT116 cells,
incubated with and without capsaicin and resveratrol, yielded ferrocytochrome c concentrations
that were not statistically different from medium alone, confirming that activated and unactivated
epithelial cells produce little or no extracellular 02-.
3.4. Discussion
The present study provides the first relatively direct measurements of the rates of NO, 02,
and 02 production and consumption by primary macrophages (BMDM) and a colonic epithelial
cell line (HCT116) under simulated inflammatory conditions. Included also are new data for a
macrophage-like cell line (RAW264.7) that had been studied previously using the same
methodology. The results for activated RAW264.7 cells in the closed chamber (Table 3.2) are
comparable to the previously reported values of kg = 4.9 ± 0.6 pmol s-1 (106 cells) -1', kc = 0.6 + 0.8
s-1, ks = 0.32 + 0.07 pmol s- (106 cells)-, R,,,a = 108 + 17 pmol s- (106 cells) - ' [Nalwaya and
Deen, 2005], although there are some differences. The present rates of NO generation (kg) and
respiration (Rmax) are each about one-half the previous values, and the rate constant for NO
consumption (k) is about twice that reported before, whereas the cellular rate of 02- generation
(ks) is nearly identical to the previous value. The maximum NO concentrations generated by
RAW264.7 cells in the closed chamber (0.2 - 0.4 pM) were also very similar to those found
before [Nalwaya and Deen, 2005]. With one-half the rate of NO synthesis and the same rate of
02- generation, the present 02/NO synthesis ratio is twice the previous value (0.14 vs. 0.07).
The numerical differences aside, the present results confirm that NO is synthesized by
RAW264.7 cells in large excess relative to 02-.
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Respiration in unactivated RAW264.7 cells was similar to that in BMDM and HCT116
cells. The 02 consumption rates for each equaled Rmax,, the measured values of that parameter
(Table 3.2) being within the range reported for other mammalian cells [Yamada, et al., 1985;
Balis, et al., 1999]. Also consistent with findings for other cells is that the rate of 02
consumption in the absence of NO was constant [Yamada, et al., 1985; Balis, et al., 1999], as
exemplified by the linear plot in Figures 3.3-3.5. Activation of macrophages (both RAW264.7
and BMDM) did not change their overall rates of 02 consumption, an approximate doubling of
the maximum rate of respiration (Rmax, Table 3.2) compensating almost exactly for the inhibitory
effects of NO. Despite the added demand for 02 associated with NO synthesis and NO
consumption, 02 consumption by activated macrophages remained mostly respiratory.
Assuming Co = 200 gM and CNO = 0.5 jaM, which are representative of concentrations
measured in the closed chamber experiments, the NO synthesis and consumption terms in
Equation 3.4 account for only about 10% of total 02 consumption. The remarkable constancy of
total 02 consumption suggests that iNOS expression may be linked to the respiratory needs of
the cell. That is, the rate of NO synthesis, and therefore the NO concentration, may be capped at
a level which does not depress the respiration rate below that of an unactivated cell.
Although it is possible that lower, physiological 02 concentrations could affect iNOS
gene expression and thus the rates of NO synthesis reported here, the available findings
concerning 02 are contradictory. Otto and Baumgardner (2001) determined that iNOS activity
paralleled the 02 levels over a wide range, whereas Palmer et al. (1998) found an increase in
iNOS protein when P0 2 was lowered. McCormick et al. (2000) reported that the amount of iNOS
protein was unaffected by Po2. Thus, more data are needed to examine the possible effects of 02
and NO on total iNOS activity.
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The rate constant for NO consumption by either type of macrophage (kc = 1.3 - 1.6 s-1, Table
3.2) is in the range of reported values for other cell types, including NH32 (0.1 s-1) and 3TC3
cells (1.7 s-1) [Wang, 2003]. Our results support the possibility that NO can also be consumed by
iNOS due to NO rebinding to form N0 3- via the 'futile pathway' of iNOS. As discussed by
Nalwaya and Deen (2005), kc can be interpreted as the sum of the NO consumption rate for
unactivated macrophages (kc) and an additional term for iNOS NO consumption (k/K), where K
is the hypothetical upper bound for CNO that would be achieved at steady state by iNOS acting
alone. Using previously measured rates for NO consumption by unactivated RAW264.7 cells
(0.9 s-1), the value of kg from Table 3.2 for BMDM, and the value of K (3.4 tM) determined
from the modeling results of Santolini et al. (2001), the calculated rate for NO consumption rate
by activated macrophages with consideration of NO consumption by iNOS is 1.7 s-1, which is in
good agreement with our measured values of kc, (Table 3.2).
Nevertheless, consumption of NO by macrophages is only marginally significant relative
to NO synthesis. For instance, at CNO = 0.5 tM, the cellular rate of NO consumption by BMDM
would be 0.5 pmol s-1 (106 cells) -1', which is about 20% of the rate for NO synthesis (kg, Table
3.2). At higher NO concentrations, or with higher values for ke, as is the case with colonic
epithelial cells, NO consumption becomes a larger fraction of NO synthesis and therefore has
more impact on net synthesis. The rate constant for NO consumption by HCT1 16 cells (kc,
Table 3.2) is approximately double that of macrophages, but still in the range of reported rates
for other cell types including NH32 human lymphoblast (0.1 s-1) , 3TC3 pancreatic beta cells
(1.7 s-1) [Wang, 2003] , and MLE murine lung epithelial cells (9 s-1) [Gardner et al., 2001]; NO
consumption rates for another colonic epithelial cell line (Caco-2) are even higher (37.7 s-1)
[Gardner, et al., 2001], suggesting a great degree of variability amongst cell-lines. As suggested
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by the values of kg for HCT116 in Tables 3.2 and 3.3, the rate of NO synthesis by epithelial cells
can be similar to that of macrophages. Thus, depending on the value of k,, colonic epithelial
cells may consume half or more of the NO that they synthesize.
Plots of NO and 02 concentrations (Figure 3.6) and superoxide synthesis (Figure 3.11)
for BMDM activated with IFN-y and LPS were nearly identical to those of activated RAW264.7
cells (Figures 3.7 and 3.12). Accordingly, the NO, 02, and 02 synthesis and consumption rates
for primary bone marrow-derived macrophages and RAW264.7 cells (Table 3.2) were
statistically indistinguishable. This similarity in cellular kinetics complements early work
showing comparable rates of NO2- and NO3- formation in primary peritoneal macrophages and
macrophage cell lines [Stuehr and Marletta, 1987]. The nearly identical kinetic behavior of
RAW264.7 cells and primary macrophages confirms the suitability of the former for in vitro NO
toxicity studies. In other words, co-culture of target cells with RAW264.7 should yield realistic
concentrations of reactive nitrogen species. It should be noted, however, that RAW264.7 cells
may differ from primary macrophages derived using other methods; for instance, LPS-treated
RAW264.7 cells produce much greater quantities of TNF-a than resident peritoneal
macrophages [Rouzer, et al., 2005].
Monitoring closed-chamber NO and 02 concentrations for HCT 116 cells treated with
capsaicin and resveratrol (as in Figure 3.8) demonstrated that colonic epithelial cells are capable
of synthesizing NO at rates comparable to macrophages, quantified the ability of this cell line to
consume NO, and confirmed the expected inhibitory effect of NO on respiration. To create
conditions that would more closely mimic intestinal inflammation, additional experiments were
performed in which HCT116 cells were infected with H. cinaedi. Due to potential contamination
of the NO electrode by the bacteria, rates of NO synthesis by infected cells were calculated from
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NO2- concentrations measured by Griess assays in an open system. At a bacterium-to-
mammalian cell ratio (MOI) of 100, NO2- concentrations measured in the supernatant of
HCT116 cells pretreated with TNF-a and IFN-y and infected were four-fold higher than with
uninfected HCT116 cells (Figure 3.9). Samples infected at MOI = 10 did not show increased
N02- accumulation, indicating that a minimum cell number ratio is needed to stimulate NO
production by epithelial cells. The use of killed H. cinaedi in the infection protocol did not
induce NO production in HCT116 cells, suggesting that viable, motile bacteria are necessary.
Without IFN-y and TNF-a pretreatment, live H. cinaedi infection did not elicit NO
synthesis from HCT116 cells, indicating that one or more signaling components must be
recruited in advance of bacterial exposure. The toll-like receptors (TLRs) serve as receptors for
various microbial products; in particular, TLR4 functions as the main receptor for LPS from
gram-negative bacteria and thus is required for effective LPS signal transduction. HCT116 cells
have been shown to be non-responsive to LPS stimulation in terms of IL-8 production largely
because of their limited TLR4 expression [Suzuki, et al., 2001]. Consequently, HCT116 cells
may respond to LPS from H. cinaedi through a mechanism independent of surface expression of
TLR4. In a murine small-intestinal epithelial cell line, Hornef et al. found TLR4 in the Golgi
apparatus which colocalized with internalized LPS [Hornef, et al., 2002]. Thus the combination
of TNF-a/IFN-y pretreatment and live, motile bacteria may augment the incorporation of LPS
into cytoplasm in HCT116 cells, which can provide signals for NO production through
intracellular TLR4 complexes. Additional studies are needed to clarify the mechanisms by
which bacteria induce NO production in colonic epithelial cells during infection.
Infection with H. cinaedi also elicited NO production by macrophages. The rates of NO
synthesis for infected RAW264.7 cells were remarkably similar to those obtained by using just
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IFN-y and LPS to activate the macrophages in the open system (kg, Table 3.3). Also, the rates
for RAW264.7 cells activated with IFN-y and LPS were found to be the same in the open system
as in the closed chamber (kg, Tables 3.2 and 3.3). Although NO2- accumulation after 24 h was
nearly identical for infected RAW264.7 cells and infected HCT116 cells (Figure 3.10), the rate
of NO synthesis by the latter was calculated to be about 50 % greater than by the former. This is
a reflection of the higher rate constant for NO consumption in HCT116 cells, measured in
separate experiments (kc, Table 3.2). Previous estimates of epithelial NO synthesis rates span
some two orders of magnitude, ranging from 0.9 fmol s-1 (106 cells) -1' to 0.2 pmol s-1 (106 cells) -'
[Wright, et al., 1999; Witthoft, et al., 1998]. Our rate of 3.9 pmol s-1 (106 cells) - for infected
HCT116 cells is much higher than any of the reported values. Contributing to this is that our
open-system calculations accounted for NO loss to the headspace, which is commonly neglected.
As shown in Table 3.3, the fraction of NO lost was calculated to range from 30% to 80% of that
synthesized, depending on the liquid depth and cell type. The cell type is influential because
cellular consumption of NO combines with extracellular autoxidation to compete with NO
diffusion to the headspace. If the reaction-diffusion model had not been used to correct for NO
losses, the rates of NO production in the open-system experiments would have been
underestimated by as much as five-fold. The excellent agreement found between the closed-
chamber and open-system values of kg for RAW264.7 cells provides confidence in the
corrections made for NO loss.
A computational model designed to predict NO concentrations in a colonic crypt during
inflammation was developed previously [Chin, et al., 2008]. By using differential equations to
describe rates of diffusion and reaction of NO and 02 in an idealized representation of the crypt
anatomy, concentrations are obtained as a function of position. In addition to the crypt shape and
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Figure 3.13. Predicted NO concentrations in an inflamed colonic crypt. Concentrations at the
crypt center are plotted as a function of height above the base. The calculations assumed that kc
= 1.3 s- 1 for macrophages and 4.1 s-1 for epithelial cells, based on the BMDM and HCT116 data
in Table 3.2. The rate of NO synthesis used for macrophages was 2.3 pmol s-1 (106 cells) -
(Table 3.2); using the cell volume (v) in Table 3.1, this corresponds to a volumetric rate of 2.4
gM/s. Results are shown for three assumed rates of NO synthesis by epithelial cells: 0, 1.2, 4.2
gM/s. The latter values correspond to the HCT116 data for capsaicin-resveratrol in Table 3.2
and H. cinaedi in Table 3.3, respectively, again using v from Table 3.1. All other parameter
values were as given in Chapter 2.
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dimensions, key inputs in that model are the rates of NO synthesis and consumption by
macrophages and epithelial cells. The rate constants for NO synthesis and consumption by
BMDM and HCT116 cells in Tables 3.2 and 3.3 yield the results shown in Figure 3.13, in which
the NO concentration is plotted as a function of height above the base of a crypt. Three cases are
considered: (i) NO synthesis by macrophages only; (ii) NO synthesis by both macrophages and
epithelial cells, using for the latter the capsaicin-resveratrol kg for HCT1 16 cells; and (iii) NO
synthesis by both cell types, using for epithelial cells the kg for infected HCT1 16 cells. The
localization of macrophages near the base of the crypt causes the NO concentration to be largest
there, whether or not there is epithelial synthesis of NO. The greater the total rate of NO
synthesis (macrophage plus epithelial), the larger the maximum NO concentration, which ranges
from 0.11 tM to 0.21 pM for the three cases. Because epithelial cells line the entire crypt, their
synthesis of NO tends to cause elevated NO concentrations to persist even in the upper part.
Even using the highest measured rates of epithelial NO synthesis (corresponding to
infected HCT116 cells), the concentrations in Figure 3.13 are below the cytotoxic thresholds
found when NO concentrations have been precisely controlled. The minimum NO concentration
at which loss of viability was detected in human lymphoblastoid (TK6) cells was 0.5 [tM [Wang,
eta 1., 2003; Li, et al., 2006], and other cell types, including HCT116, have been shown to be
more resistant to NO [Li, et al., 2009]. Thus, even if epithelial cells in vivo are as sensitive to
NO as TK6 cells, our model predicts that they will remain viable. At these sub-cytotoxic
concentrations, exposure to NO and related reactive nitrogen species may initiate a mutagenic
change in the population of epithelial cells within the colonic crypt that causes irregular
proliferative behavior and ultimately leads to cancer. Alternatively, at the sub-micromolar NO
concentrations, NO may act synergistically with low oxygen to induce cell death; due to
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reversible binding to cytochrome oxidase, even low (nM) concentrations of NO are sufficient to
inhibit electron transport at physiological oxygen levels [Brown and Cooper, 1994]. In either
case, the concentration estimates for colonic crypts that we have obtained from cellular kinetic
measurements and modeling provide guidance in selecting experimental conditions that should
be useful in elucidating the molecular biological linkage between NO exposure and
carcinogenesis in IBD.
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Chapter 4. Predicting Nitric Oxide Concentrations in Melanoma
4.1. Introduction
Nitric oxide may play a role in the growth and metastasis of melanoma, the most
malignant of skin cancers [Grimm, 2008; Balch, et al., 2001]. The presence of inducible nitric
oxide synthase (iNOS) and nitrotyrosine provides evidence of NO production within some
human melanomas, and these two markers for NO are correlated with poor survival rates of
patients [Ekmekcioglu et al., 2000]. Studies with melanoma cells suggest that NO derived from
iNOS may stimulate proliferation as well as promote resistance to apoptosis [Tang and Grimm,
2004]. However, efforts to establish mechanistic links have been hampered by the absence of
information on NO concentrations. Our objective was to provide concentration estimates by
combining cell kinetic data with a mathematical model designed to describe reactions and
diffusion of NO in cutaneous melanomas.
Metastatic melanomas are typically in the vertical-growth phase and can penetrate more
than 4 mm into the dermis, sometimes reaching the subcutaneous tissue before spreading to
regional lymph nodes [Morton et al., 2006]. A network of blood vessels and capillaries extends
upwards from the subcutaneous tissue into the dermis, as shown schematically in Figure 4. la.
The tumor stroma, or interposing region between malignant melanoma cells and normal dermal
tissue, consists of fibrillated extracellular matrix components to form the interstitial connective
tissue that accommodates the expansion of the tumor mass as it invades surrounding tissue. In
cutaneous melanomas, the stroma often includes inflammatory cells such as macrophages and
the infiltration of macrophages has also been linked to tumor growth [Torisu et al., 2000]. Thus,
synthesis and consumption of NO by macrophages as well as melanoma cells must be taken into
account when estimating NO concentrations. Nitric oxide synthesized within a cell can readily
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Figure 4. 1. (a) Schematic representation of a cutaneous melanoma. (b) An enlargement of the
area enclosed in the dashed box in Figure 4.1 a that represents the edge of a melanoma tumor.
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cross cell membranes and diffuse to neighboring cells. Its permeation through lipid bilayers and
diffusion through water are both very similar to that of 02 [Subczynski et al., 1996; Zacharia and
Deen]. Nitric oxide is consumed by autoxidation, intracellular pathways which are both
enzymatic and non-enzymatic, and oxidation by oxyhemoglobin. Each of these rate processes
requires consideration when simulating NO levels in melanomas.
The uncatalyzed reaction of NO with 02 (autoxidation) yields NO2- as the end-product,
with NO 2 and N2 0 3 formed as intermediates [Lewis et al., 1995]. The overall stoichiometry of
this multi-step oxidation is
4NO + 0 2 - 2N203 +2H20 > 4NO2+4H+ . (4.1)
This reaction will occur both within cells and in extracellular spaces. However, although it is
important in culture media and was taken into account in the experiments to be reported, it is too
slow to have a significant effect on NO concentrations within a melanoma, as will be shown.
One pathway for the intracellular consumption of NO involves its rapid reaction with 02 to form
peroxynitrite (ONOO-) and NO3- [Ischiropoulos et al., 1992; Huie and Padmaja, 1993]:
NO + O2 - ONOO- C2 NO 
.  
(4.2)
Because 02- is a byproduct of respiration and this reaction is fast enough to compete with
superoxide dismutase, it is expected to occur in virtually all cells. Other pathways for
intracellular consumption of NO involve nitrogen dioxygenases [Gardner et al., 2000], and
reactions with oxygen-ligated reduced metals [Eich et al., 1996]. Measurements of NO
consumption by rat hepatocytes indicate that the overall intracellular NO consumption rate can
be modeled as being first-order in NO concentration [Thomas et al., 2001], which is consistent
also with data from our laboratory for various cell types [Nalwaya and Deen, 2005; Chin and
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Deen, 2010]. Lastly, any NO that reaches blood vessels is depleted by its rapid reaction with
oxyhemoglobin (HbO 2) to form methemoglobin (metHb) and N03- Eich et al., 1996]:
NO + HBO 2 - metHB + NO (4.3)
Accordingly, capillaries act as very effective sinks for NO in tissues.
It should be mentioned that Reaction 4.2 can also lead to a certain amount of NO
consumption outside cells, because activated macrophages synthesize extracellular 02 via a
membrane-bound NADPH oxidase [Babior, 1984; Berton et al., 1988]. However, the diffusion-
limited kinetics of Reaction 4.2, together with the fact that NO production exceeds extracellular
02- synthesis, makes this an extremely localized process. It has been estimated that the 02
produced by a macrophage is fully exhausted within 1 p~m of the cell [Chen and Deen, 2002].
Moreover, the rate of sustained 02- release into the surrounding media by a macrophage has been
found to be only about 10% of its rate of NO production [Chin et al., submitted 2009]. For these
reasons, extracellular consumption of NO by 02 can be neglected when modeling NO
concentrations in tissues.
To provide the cell kinetic data needed for a reaction-diffusion model, NO synthesis and
consumption were studied in a melanoma cell line, A375. Studies involving A375 cells suggest
that endogenous NO is responsible for melanoma growth; A375 cells have been shown to
constitutively express iNOS [Zheng, et al., 2004] and treatment of A375 cells with a NO
scavenger (c-PTIO) has resulted in decreased cell growth [Grimm, et al., 2008]. Complementing
the A375 data were previous measurements of NO synthesis and consumption in a macrophage
cell line and in primary mouse macrophages, as described in Chapter 3. This cellular information
was combined with other data on the rates of NO diffusion and reaction in aqueous media and
with the anatomical length scales to simulate steady-state NO concentrations within a melanoma.
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4.2. Materials and Methods
4.2.1. Cell Culture
A375 melanoma cells were obtained from American Type Culture Collection and were
cultured in Dulbecco's modified Eagle's medium (DMEM) containing L-glutamine
supplemented with 100 U/mL penicillin, 100 ug/mL streptomycin, and 10% (v/v) heat-
inactivated fetal bovine serum (FBS) (BioWhittaker, Walkersville, MD). All cells were
maintained at 37 'C in a humidified 5% CO2 atmosphere.
4.2.2. NO Synthesis by A375 Cells
To assess the synthesis of NO by A375 cells under simulated inflammatory conditions,
the supernatant of cells incubated in media with and without TNF-a (50 ng/mL) and IFN-y (100
U/mL) was assayed for NO2- accumulation. The number of viable cells was determined by
trypan blue exclusion and cells were seeded at concentrations of I x 106 cells/well into 6-well
plates. Supernatant samples (1 sample per well) were collected at 24 and 48 hours after
stimulation and centrifuged at 12,000 rpm before analysis. Nitrite accumulation was quantified
using a Griess assay kit (R&D Systems, Minneapolis, MN). Briefly, 50 [L of culture
supernatant was allowed to react with 100 pL of Griess reagent and incubated at room
temperature for 10-30 min. Absorbance was measured at 540 nm using a microplate reader.
4.2.3. NO Consumption by Culture Medium and A375 Cells
For studies with culture medium alone, saturated NO solutions were prepared by
equilibrating PBS with 10% NO gas. Oxygen was first purged from the PBS by bubbling the
solution with Ar in a septum-sealed bottle. The NO gas, passed through a soda-lime column to
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remove any NOx impurities, was then bubbled into the deoxygenated PBS. A 50 mL septum-
sealed glass flask with a magnetic stir bar was used to determine the rate of NO consumption in
DMEM with 25 mM HEPES (pH 7.4). After the vial was filled with the test liquid, NO was
introduced by injecting 50 to 200 [tL of the saturated PBS solution through the septum, to give a
mixture concentration of 1-5 tM. The rate of NO consumption was calculated as described
below from the decay of the NO concentration, which was monitored continuously with an
electrode (World Precision Instruments, Sarasota, FL) inserted through the septum. The
experiments were carried out in a warm room at 37 'C and in the dark to minimize light-sensitive
02- generation from the riboflavin in the media [Keynes et al., 2003].
Rates of NO consumption by A375 cells were measured in a similar manner, but using a
different closed chamber. A polycarbonate insert was machined to fit within standard 60 mm
polystyrene tissue culture dishes and equipped with a stirring motor (Instech Laboratories,
Plymouth Meeting, PA), NO electrode, and fiberoptic 02 sensor (Instech Laboratories, Plymouth
Meeting, PA), as depicted in Figure 3.2. After assembly the chamber had a total liquid volume
of 8.8 mL. The number of viable cells was determined by trypan blue exclusion and between 3 x
106 and 5 x 106 cells were seeded onto 60 mm dishes. After the cells were allowed to adhere for
2-3 h, fresh, preheated media with 25 mM HEPES was added to the dish and the insert was
attached. Between 50 and 100 L of NO in PBS was introduced through an injection port in the
apparatus, giving initial NO concentrations of 1-5 [tM. The NO concentration was monitored
until it approached zero, typically 10-15 min. To check an assumption made in the kinetic model
(see below), 02 concentrations were also measured in some of the cell experiments.
4.2.4. Kinetic Model for NO Consumption in Vitro
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The closed chambers were modeled as well-stirred batch reactors, as described previously
in Chapter 3. In general, the variation in NO concentration (CNo) with time (t) is governed by
dCNo m(k, - vkCNO) - 4kaCNO2 C0 2 - k,,, (4.4)
dt V
where m is the number of viable cells, V is the liquid volume, v is the volume of a single cell,
(modeled as a hemisphere with radius = 7.5 pm [Sheriden et al., 1981]), kg is the rate of
generation of NO, kc is the rate constant for intracellular consumption of NO, ka is the rate
constant for autoxidation of NO, and k,, is the rate of extracellular NO consumption by culture-
medium-generated 02-. The values for V, v, and ka are given in Table 4.1, and the number of
cells was known for each experiment. The experiments were designed to evaluate kg, ke, and k,.
In the absence of cells, Eq. 4.4 reduces to
dCN 4  2dC = -4kaCNO2  - k,,, (4.5)
dt
and the corresponding 02 balance is
dCdC = -kC2 C (4.6)
dt2
Preliminary calculations in which Eqs. 4.5 and 4.6 were solved together numerically showed that
02 consumption by autoxidation is negligible for the NO and 02 concentration ranges in our
experiments with media. Accordingly, Eq. 4.6 was discarded and Co2 in Eq. 4.5 was
approximated by the liquid-phase 02 concentration in equilibrium with air ( Co ). The value
used (Table 4.1) was based on the solubility of 02 in water at 370C [Lange, 1967]. For this
circumstance with constant C, , the solution of Eq. 4.5 is
k,,k a Co0  2koCCNo(t) = 2 tan -2t kmka C + arctan C02 (4.7)
a 02 kk C02)
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where C"o is the initial NO concentration. With ka being known (Table 4.1), km was found by
minimizing the root-mean-square difference between the measured and calculated NO
concentrations, using Microsoft Excel (Microsoft, Redmond, WA).
With cells present, there was a 5-8% decline in 02 concentration during the four
experiments in which it was measured. Two approaches were compared for evaluating the 02
concentration when calculating kc from the cellular NO data. In one, the measured, time-
dependent values of Co0 were used in the differential equation for NO. In the other, Co2 was
approximated as a constant, equal to 97% of Co2 . Because the values of kc obtained using the
two methods differed by less than 1%, the second (simpler) method was adopted. With constant
Co, , the solution of Eq. 4.4 is
B tB 8VkCCo + mvk mvk,S(t) = tanh - + arctanh a C (4.8)
8kaCo2V 2V B j 8kaCO2V
B= 6VkkC -1 C 2 022k 2
0 16mVkkC -16V k,,,ka2 2+ m ck (4.8b).
Given m (as determined for each experiment), the values for v, V, and ka listed in Table 4.1, and
with kg and k,, evaluated from separate experiments, kc was calculated by minimizing the root-
mean-square difference between the measured and calculated NO concentrations using the
simplex method in MATLAB (MathWorks, Natick, MA).
4.2.5. Melanoma Model
The modeling of chronically elevated NO concentrations in body tissues differs from that
in the in vitro experiments in three ways. First, the concentrations are nearly time-independent.
A steady-state assumption is justified for melanoma by the fact that the time required for NO to
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Table 4.1. Parameters used in the kinetic model for the closed chamber apparatus to fit kc
Parameter
V
v
ka
Co
01,
Value
8.8 x 10-3 L
8.8 x 10- 13 L
2.6 x 106 M -2 S-1
223 CiM
Reference
see text
see text
Lewis and Deen, 1994
Lange, 1967
Symbols: V, liquid volume in the closed chamber; v, volume of a single cell; ka, rate constant for
autoxidation of NO; C" , liquid-phase 02 concentration in equilibrium with air.
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diffuse within a tumor is much shorter than the weeks to months required for significant tumor
growth. The time for diffusion over a distance d with diffusivity DNO is approximately d2/DNo,
or about 2 h for L = 4 mm and DNO = 2.0 x 10-5 cm 2/s. Second, the NO concentration will vary
with position, declining with increasing distance from sites of NO synthesis, according to the
competition between rates of diffusion and consumption. Third, anatomical dimensions and the
locations of different cell types must be taken into account.
In general, the simultaneous synthesis, diffusion, and consumption of NO under steady-
state conditions in a given tissue is described by
D NV 2 CNO +kg -kcCNo 
-4kaCNO 2 C O =0 (4.9)
where V2 is the Laplacian operator. The application of this conservation equation to melanoma
is simplified by the fact that NO consumption by cells is rapid enough to localize the elevations
in NO concentration. The length scale which results from the competition between diffusion and
cellular consumption is (DNo/kc)1/ 2, and our results for melanoma indicate that this is only a few
tens of Jm, as will be shown. For this reason, and because NO synthesis appears to occur mainly
in a thin layer of macrophages surrounding the tumor, only the edges of the melanoma had to be
modeled. Moreover, for length scales less than about 100 tm, autoxidation is too slow to
compete with diffusion and cellular consumption, so that the ka term in Eq. 4.9 could be
neglected. Because the 02 concentration appears only in the autoxidation term, it was
unnecessary to solve a second differential equation for 02. The rationale for these
approximations is discussed further in Appendix B.
Based on the foregoing, the modeling could be confined to three adjacent regions at the
periphery of the tumor. As depicted in Figure 4. 1b, the regions correspond to tumor cells, stroma
with macrophages, and dermal tissue, respectively. Because the thickness of the regions
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modeled is much smaller than the dimensions of invasive melanomas (typically on the order of
several mm), tumor shape is unimportant and position (x) could be measured relative to the
tumor-macrophage boundary, as shown. The simplified form of Eq. 4.9 is
d2
DNO +k -kCO =0 (4.10)
In subsequent expressions, the concentrations in the melanoma (Cuo) are distinguished
from those in the stroma region ( CNO ) and dermal tissue ( CN). In particular, in the stroma,
where macrophages and stromal tissue cells are present, Eq. 4.10 becomes:
d2
Dx 2 9 O - Co = 0 (4.11)
where 0 is the volume fraction of macrophages in the region and all other parameters are the
same as those previously defined. The baseline model assumes the tumor stroma is composed
entirely of macrophages (0 = 1), and represents an upper bound for NO concentrations in
melanomas. Inherent in Equation 4.11 is the assumption that stromal tissue cells do not
synthesize NO but that they consume NO at the same rate as macrophages. The general
solutions to Eq. 4.10 for the three regions are:
CNo (x) = AexkcIDNO + kg /k, (-oo < X < 0) (4.12)
CNo(x)= Bcosh( k/Dox)+Csinh (L/DNox)+og/k (0 <x < L) (4.13)
CN (x) = De-x'  (L < x < oo) (4.14)
The constants A, B, C, and D were evaluated by matching NO concentrations and fluxes at the
melanoma-macrophage and macrophage-dermal tissue interfaces. The somewhat lengthy
expressions are given in Appendix B.
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4.2.6. Parameter Values
The baseline parameter values are given in Table 4.2; unless otherwise stated, all
calculations were done using these values. The diffusivity of NO was taken to be two-thirds of
its aqueous value, which is the intracellular/aqueous diffusivity ratio for 02 [Ellsworth and
Pittman, 1983]. Use of the oxygen diffusivity ratio is justified by the nearly identical diffusional
characteristics of NO and 02 in water [Zacharia and Deen, 2005]. The thickness of the
macrophage region, L, assumes a single layer of cells with average diameters of 15 tm
[Leskovar, et al., 2000].
Whereas intracellular consumption takes place in all three domains, synthesis is assumed
to occur only in the macrophage region for the baseline model. As indicated in the Results, we
were unable to detect NO production by A375 melanoma cells. The rates of NO production and
consumption for macrophages (k g , ) in Table 4.2 are based on direct measurements in primary
bone marrow-derived macrophages activated with recombinant mouse interferon-y (IFN-y) and
Escherichia coli lipopolysaccharide (LPS). As described in Chapter 3, cellular kinetic
parameters were determined by monitoring time-dependent NO and 02 concentrations in a
closed chamber and fitting data to a kinetic model, similar to what was done in the present study.
The rates of NO consumption by melanoma cells, measured using the method described earlier,
are described fully in the Results. Cellular NO consumption in the dermal tissue was assumed to
be equivalent to that in macrophages. It has been found, for example, that NO consumption rates
in TK6 cells (a human lymphoblastoid cell line) are roughly the same as those in RAW264.7
cells [Nalwaya and Deen, 2005] and [Wang et al., 2003].
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Table 4.2. Baseline Values of Diffusivities, Rate Constants, Concentrations and Length Scales
for Melanoma Model
Parameter Value Reference
Duo, Duo, Duo 2.0 x 10-5 cm2 /s See text
L 15 ipm Leskovar, et al., 2000
kg 0 This work, see text
k 2.4 pM/s Chapter 3
kC 7.1 s-1  This work, see text
kc , kc 1.3 s
-1 Chapter 3
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4.3. Results
4.3.1. NO Synthesis by A375 Cells
NO production by A375 melanoma cells was not detected using Griess assays, even with
the addition of systemic inflammatory factors, TNF-a (50 ng/mL) and IFN-y (100 U/mL), which
induce iNOS expression in various other cell types [Maciejewski, et al. 1995; Bogdan, 2001].
Moreover, previous works have measured nitrite accumulation, as assessed with the Griess
assay, for other NO-producing cell types [Gellar, et al., 1993; Chan et al., 1999]. Thus, because
melanoma cells appear to generate NO at rates low enough to be considered negligible compared
to macrophages, NO synthesis by melanoma cells (kg) was assumed to be zero for the baseline
case.
4.3.2. NO Consumption in Media
Figure 4.2 shows representative results for NO concentrations as a function of time in
DMEM with HEPES, measured in the absence of cells and in the dark. After the injection of
saturated NO solution at t = 0, the NO concentration decreased due to consumption from the
autoxidation reaction and from media-generated 02-. The NO decline from autoxidation alone
(in a separate experiment) is also shown; the difference between these curves represents NO
consumption from media-generated 02-. Averaged over all experiments, the consumption of NO
by DMEM in the dark (k,,), attributable to 02- production from HEPES [Keynes et al., 2003],
was found to be 0.5 + 0.3 nM s-1 (n = 3) and is in good agreement with previously reported
values [Nalwaya and Deen, 2005]. As shown by a comparison of the curves corresponding to
the calculated and measured NO concentrations, the kinetic model accurately fit the measured
data.
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Figure 4.2. NO consumption by culture media (DMEM with HEPES) in the absence or presence
(solid black) of A375 melanoma cells (4.5 x 106 cells) at 370 C in the dark. Shown is a
representative plot of NO concentration as a function of time after an injection of - 1 [M of
saturated NO solution (at t = 0). Also shown is the predicted NO decay from autoxidation
reaction alone. The dashed curves were calculated using the kinetic model, using the best-fit
values of km and kc for the respective experiments.
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4.3.3. NO Consumption by A375 cells
Figure 4.2 also shows the NO concentration in a representative experiment designed to
determine the rate constant for NO consumption by A375 cells. The concentration decrease
following injection of the saturated NO solution was more rapid than with media alone, the
difference being attributable to cellular NO consumption. The rate constant for intracellular NO
consumption by A375 melanoma cells was determined to be 7.1 ± 0.8 s-1. (The mean value is
that given already as kc in Table 4.2.)
4.3.4. Predicted NO Concentration Profiles
Figure 4.3 shows NO concentrations, calculated with the baseline model parameters, as a
function of position (relative to the edge of the tumor) within the melanoma, macrophage, and
dermal regions. In this and subsequent plots, the macrophage monolayer extends from x = 0 to x
= 15 pm. As shown, the NO concentration reaches a maximum of 0.22 gM in the macrophage
region and declines rapidly in the melanoma and dermal regions; in the melanoma tumor,
roughly 90% of the NO is consumed within 30 [tm of the macrophage layer. In the dermis, NO
decays slightly slower due to the lower rates of NO consumption assumed in the tissue, and gives
rise to a NO profile that is not symmetrical about the macrophage layer.
4.3.5. Effect of Varying Macrophage Density
Although there are limited data on macrophage counts, the assessment of tumor-
infiltrating macrophages appears to be subject to great inter-observer variability [Busam et al.,
2001]. Moreover, in malignant melanoma, the pattern of the macrophage population changes in
the course of tumor progression [Brocker et al., 1988]. Given the uncertainty of the number and
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distribution of macrophages within the stroma, the effect of varying macrophage density on NO
concentrations in the melanoma was also modeled. Macrophages were assumed to be distributed
homogeneously in a layer of stromal tissue (of thickness, L) and the volume fraction of
macrophages (0) within the region was varied.
Concentration profiles for three different macrophage volume fractions (with 0 = 1
corresponding to the baseline monolayer model) are also depicted in Figure 4.3. Decreasing the
volume fraction of macrophages from 1 to 0.5 and 0.1 has the effect of decreasing the overall
volumetric NO synthesis rate, resulting in maximum NO concentrations of 0.1 and 0.02 jiM
respectively. Maximum NO concentrations increase linearly with increasing /, which is a
consequence of having a linear differential equation with one source term (0 kg in Eq. 4.11).
4.3.6. Effect of Melanoma NO synthesis
Although the baseline model assumes NO is not generated within the melanoma, it is
conceivable that melanoma cells synthesize NO at low rates. In modeling intratumoral NO
production, the melanoma NO synthesis rate is assumed to be a fraction of the macrophage NO
synthesis rate (k , Table 4.2). Thus, instead of decaying to zero, as seen in the baseline model,
the NO concentration far from the macrophage monolayer is a balance of melanoma NO
synthesis and intracellular consumption. The NO concentration profiles for the intratumoral
synthesis model are compared with the baseline model in Figure 4.4, where the volumetric rate
of NO synthesis in the tumor region (kg) was assumed to be 10%, or 20% that of macrophages.
NO concentrations as a function of position are depicted once again. As seen, the maximum NO
concentration remains unchanged in the macrophage monolayer (0.22 CPM), but with
intratumoralNO synthesis, NO levels far from the macrophage layer are sustained at 35 and 70
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Figure 4.3. Predicted NO concentrations in the periphery of a tumor for the melanoma,
macrophage, and dermis regions depicted in Figure 4.lb. Macrophage volume fractions are
varied in the region extending from x = 0 to x = 15 pm. The baseline model assumes that this
space was fully occupied by macrophages (i.e. = 1, where 0 is the volume fraction of
macrophages) and two other macrophage densities are also depicted. All calculations employed
the baseline parameter values listed in Table 4.2.
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Figure 4.4. NO concentration as a function of distance from the edge of a melanoma with
intratumoral NO synthesis. NO profiles in the melanoma, macrophage, and dermis are shown
for various melanoma synthesis rates that correspond to 0% (same as baseline), 10%, or 20% of
the macrophage NO synthesis rate.
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Table 4.3. Comparison
mammalian cell types
of rate constants for intracellular NO consumption by various
Cell Cell Type kc (s'1) Reference
Human lymphoblast
Human lymphoblast
Murine pancreatic p3
Murine macrophage
Murine macrophage
Human colonic epithelial
0.1
0.3
1.7
0.6-1.6
1.3
4.1
Human melanoma
Rat hepatocyte
Rat adrenal
pheochromocytoma
Human myelogenous
leukemia
Murine lung epithelial
Human lung adenocarcinoma
Human colonic epithelial
Wang, 2003
Wang, 2003
Wang, 2003
Nalwaya and Deen, 2005,
Chin, et al., submitted 2009
Chin, et al., submitted 2009
Chin, et al., submitted 2009
this work
Gardner et al., 2001
Gardner et al., 2001
Gardner et al., 2001
Gardner et al., 2001
Gardner et al., 2001
Gardner et al., 2001
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NH32
TK6
3TC3
RAW264.7
BMDM
HCT116
A375
K9
PC12
K562
MLE
A549
Caco-2
nM within the melanoma for kg = 0.24 and 0.48 [M/s respectively.
4.4. Discussion
We developed a mathematical model to estimate spatially varying NO concentrations in a
cutaneous melanoma. By using differential equations to describe rates of diffusion and reaction
of NO in an idealized representation of a melanoma tumor, concentrations are obtained as a
function of position. Key inputs in the model were the rates of NO synthesis and consumption
by macrophages (previously determined [Nalwaya and Deen, 2005; Chin and Deen, 2010]) and
melanoma cells. NO synthesis by A375 melanoma cells was not detected using Griess assays,
which is consistent with previously published results. Although iNOS expression in A375 and
MeWo cells has been demonstrated, NO levels in those studies were barely detectable in liquid
culture [Zheng et al., 2004]. Others have also reported negative Griess results for K-1735 C4
murine metastatic melanoma cells [Xie et al., 1995] and G361, a human melanoma cell line
[Andrews et al., 1995]. The rate constant for cellular NO consumption by A375 was found to be
7.1 s- (ks, Table 4.2), which is more than five-times the consumption rate for macrophages (k,
Table 4.2) and on the upper end of reported values for other cell types including NH32 human
lymphoblast (0.1 s-1') , 3TC3 pancreatic beta cells (1.7 s-l ) [Wang, 2003] , HCT116 (4.1 s-1) [Chin
et al., submitted 2009] and MLE murine lung epithelial cells (9 s-1) [Gardner et al., 2001] (see
Table 4.3).
Given the diffusivity of NO and measured values for ke, the length scale which results
from the competition between diffusion and consumption (-20 Im) is small enough that
intracellular reactions (such as with 02-, oxygen-ligated metals, and NO dioxygenases) are the
only important pathways for NO consumption. NO consumption via reactions with
oxyhemoglobin (Eq.4.3) was neglected because the average distance between blood vessels
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[Dadras et al., 2003; Kiss et al., 2007] is large enough that NO is likely to be consumed
intracellularly before it reaches any blood vessels. Extracellular consumption of NO by 02 was
also omitted in modeling NO concentrations, for the reasons discussed earlier.
Autoxidation was also too slow to compete with diffusion and cellular NO consumption,
allowing for NO concentrations to be uncoupled from local 02 levels. Although the 02
concentration distribution could potentially affect the rate of NO synthesis by iNOS, the
Michaelis constant for oxygen-dependent production of NO by iNOS has been reported to be
around 6 jiM; iNOS is the least 0 2-sensitive NOS isoform at low pO2 [Rengasamy and Johns,
1996]. Even with the diffusion and cellular consumption of 02 in tissue, given the supply of
oxygen from proximity of the macrophages to blood vessels (- 40 [im [Dadras et al, 2003; Kiss
et al, 2007]), the rate of cellular respiration would need to be approximately 5-times the reported
rate for macrophages [Nalwaya and Deen, 2005] for concentrations in the peritumoral region to
be as low as 6 lIM. Thus, it seems unlikely that 02 availability would be a significant factor in
iNOS-produced NO. Melanoma cells have also been shown to express the other constitutive
isoforms of nitric oxide synthase (eNOS and nNOS) [Salvucci et al., 2001; Ahmed and Van Den
Oord, 1999]. Although NO production from the other NOS isoforms may be more 02 -sensitive,
eNOS and nNOS generate low levels of NO relative to iNOS [MacMicking, et al., 1997], so the
overall NO concentrations are still unlikely to be significantly affected by variations in 02
concentrations.
Incorporating these approximations into our mathematical model, NO concentrations
were calculated for the edge of a melanoma, with maximum NO concentration (0.22 lPM)
occurring in the macrophage monolayer (Figure 4.3), and quickly decaying to zero within the
tumor. Although the specific configuration of macrophages surrounding a tumor is unclear, the
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highest NO concentrations are elicited by macrophages grouped closely together so a stroma
region comprised entirely of macrophages was used as our baseline model to represent the upper
bound for NO exposure in a melanoma. The degree of macrophage infiltration in the tumor
stroma has been shown to correlate with increased tumor depth and metastatic potential [Torisu
et al., 2000], and our model suggests that the volume fraction of macrophages in the stroma
(within a 15 [m periphery of a tumor) must exceed 50% for melanoma NO concentrations to
exceed 0.1 IM.
Intratumoral NO synthesis was also considered by assuming the volumetric rate of NO
synthesis by melanoma cells was 10% or 20% of the macrophage NO synthesis rate.
Alternatively, these results can also represent a scenario whereby 10% or 20% of the
intratumoral cells are comprised of macrophages that have infiltrated and are distributed
uniformly within the tumor mass. Unlike the baseline model, including melanoma NO synthesis
results in NO concentrations that decay to non-zero levels in the tumor. Instead, the melanoma
NO concentration far from the macrophage layer is a balance between the rates of synthesis and
consumption (kg/k,). With autoxidation unimportant, the melanoma NO concentration is
independent of local 02 levels, and potential hypoxic conditions which can develop in the center
of the tumor would not affect the predicted intratumoral melanoma NO concentrations.
On the other hand, increasing the hypothetical intratumoral NO synthesis rate
proportionally increases the NO concentrations that persist in the tumor. Given that NO levels in
liquid culture are low or undetectable with Griess assays, melanoma NO synthesis is likely to be
much less than that of macrophages. Nevertheless, even if melanoma NO synthesis is 20% that
of macrophages (equivalent to a synthesis rate of 0.5 piM/s), NO concentrations in the tumor are
only 70 nM (Figure 4.4). Normal tissue NO concentrations are unlikely to exceed 50 nM
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[Lamkin-Kennard et al., 2004]. Thus, whether or not melanoma cells themselves synthesize NO,
our model predicts that only cells at the periphery of the tumor are exposed to significantly
elevated NO concentrations.
Including blood vessels as NO sinks in the intratumoral synthesis model also had a
negligible effect on the melanoma NO concentrations far from the macrophage monolayer (- 1%
change). In fact, in applying a Krogh-type approach to represent homogeneously vascularized
tissue, incorporating NO depletion by blood vessels only increased the effective NO
consumption rate by 1.4%, as compared to intracellular NO consumption alone (see Appendix C
for detailed analysis). This is because of the distance between blood vessels (-70 tm) based on
reported intratumoral vascular densities [Dadras et al., 2003; Kiss et al., 2007].
The predicted NO concentrations are similar to results obtained by modeling NO in an
inflamed colonic crypt [Chin et al., 2008]. Despite the two different geometries and the different
cell types involved, the small length scales and proximity to a monolayer of macrophages
resulted in concentration predictions of -0.2 VM in both models. Our model may offer some
insight into the role NO plays in cutaneous melanoma tumor progression metastasis, which
preferentially spreads via the lymphatic route [Giorgadze et al., 2004]. Tumor cell proliferation
has been shown to be most pronounced at the periphery of melanomas [Straume et al., 2003].
Thus elevated NO levels may inhibit apoptosis in melanoma cells, leading to tumor growth along
the edge and facilitating the invasion of lymphatics to eventually form distant metastases. In
addition, the presence of iNOS has been correlated to lymphatic vessel densities in metastatic
melanomas, with higher vessel densities occurring in the peritumoral areas [Massi et al., 2009].
At the concentration levels predicted by our model, NO may also contribute to lymphatic
vascular formation in melanomas. NO has been shown to act as a lymphangiogenic factor
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through interaction with VEGF-C in breast cancer and head and neck squamous cell carcinomas
[Franchi et al., 2006; Nakamura et al., 2006]. Facilitating lymphatic spread through pre-existing
lymphatics or by de novo lymphangiogenesis are just two of the many possible mechanisms by
which NO may contribute to the metastasis of melanomas. With NO concentration predictions,
the intracellular concentrations of other reactive nitrogen species can also be calculated [Lim et
al., 2008], which should facilitate efforts to probe the effects of NO and its reactive products on
the pathophysiological progression of melanomas.
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Appendix A: Analytical Solution for NO Concentrations near Spherical Macrophage
Aggregates
Following is a derivation of expressions that describe the steady-state NO concentration
in a situation in which a spherical macrophage (or spherical aggregate of tightly packed
macrophages) of radius R is surrounded by a large volume of lamina propria tissue. It is
assumed that NO is synthesized in the macrophage (or aggregate) at a constant rate, and is
consumed in both regions by first-order reactions. Given the symmetry, the concentration in
each region is a function only of the spherical radial coordinate r, measured from the aggregate
center. Defining the dimensionless radial position as q = r/R, and dimensionless concentrations
in the macrophage and lamina propria regions as 0 = Co / Cuo and 6 = Co / Co, respectively,
Eq. 2.9 for the two regions becomes
q2 +1- 0 = 0
Far2), a 7 )0
(Al)(0 1 1)
(u >1) (A2)
where 8 = k R2 / DNO and Co = k R2 / DNO. Equations Al and A2 are each particular forms of
the modified spherical Bessel equation. Their general solutions are
(r) = Asinh - (A3)
11 /
()= B sinh /i C cosh 1r
0(77)--+
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(A4)
where A, B, and C are constants. Imposed already in Eq. A3 is the requirement that the
concentration be finite at r = 0. The constants were evaluated by requiring that 0 = 0 and
d0 / dr= d / dr at r= 1, and that 0 = 0 at r= oo. The results are
1+ )
/3/2 (sinh ( /+ cosh (,))
+ (1  1sinh(J +
/ (sinh 2 - cosh 2
,(1+ 8)sinh(J, +l
(A5)
(A6)
35/2 sinh () 2
(A7)
-cosh )
To obtain dimensional concentrations (as plotted in Figure 2.9), the concentrations in Eqs. A3
and A4 were each multiplied by kgR2/DNo.
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Appendix B: Analytical Solution for NO Concentrations at the Edge of a Melanoma
The magnitude of physical dimensions relative to NO consumption length scales
(DNO / k )/2 allowed for the melanoma and dermis regions to be modeled as infinite domains. As
such, the geometry of the melanoma tumor itself was unimportant and a simplified 1-
dimensional reaction-diffusion model comprised of three adjacent domains was used to calculate
NO concentrations at the tumor edge. Following is a derivation of expressions that were used to
calculate the steady-state NO concentrations in the melanoma regions depicted in Figure 4. 1b.
For purposes of simplification, scaled dimensionless variables were defined, 0 = CNO / Cuo,
y = C , / Co2 and X = x/L. The concentration scale for oxygen (Co2 ) is the 02 concentration in
venous blood (58 tM), whereas the concentration scale for nitric oxide (Cuo*) will be defined
subsequently. The length scale, L, is the thickness of the macrophage monolayer (15 jtm, Table
4.2). The dimensionless form of Eq. 4.9 is thus:
2 k9 1 4kC Co
V2k+ k 02 NO 024 = 0 (B 1)
DNOCO DNO DNO
Although the same symbol is used as before, V 2 in Eq. (B1) is now dimensionless (i.e., L2 times
that in Eq. 4.9. The concentration scale for NO was determined primarily by the rate of NO
synthesis. Since NO is assumed to be produced mainly in the macrophage layer, the coefficient
of the first reaction term in Eq. B 1 was set equal to unity for that region. The resultant NO
concentration scale was thus CNO* = 0.27 [M; our analytical solutions confirmed that this is a
good estimate of the maximum order of magnitude of CNO.
The coefficient of the autoxidation term in Eq. B 1 is a Damk0hler number that measures
the importance of autoxidation relative to diffusion. It is denoted as
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4kaCo2 CNOL
DNO
(B2)
Substituting the corresponding values from Tables 4.1 and 4.2 into Eq. B2, y << 1, implying that
autoxidation does not significantly affect the NO concentration and is justification for neglecting
the autoxidation in our calculations. Eq. B 1. thus becomes:
d 20
+a-O=0
dX2
(B3)
where the a and f are the Damkihler numbers for NO synthesis and intracellular consumption,
respectively, given by:
k L2
a= D C*
NO NO
k L2
DN
(B4)
(B5)
Equation B3 was solved analytically for all three regions in Figure 4. lb using region-specific
values of a and /. The general solution to B3 (dimensionless form of Eqs. 4.10-4.12) is:
O = AeW z + a/lP
O = Bcosh (X )
(-00oo <X < 0)
(0 < < 1)
(1 < _ oo)0 = De-~Xz
As before, 0 represents the volume fraction of macrophages in the stroma; in the baseline model,
0 was assumed to be 1. The constants A, B, C, D were evaluated by requiring that 0 = 0
,dO / d = dO / dX and 0 = 0 , dO / dX = dO / dv atX = 0 and X = 1, respectively (i.e. matching
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(B6)
(B7)
(B8)
+Csinh (18 + // P
concentrations and fluxes across the melanoma/macrophage and macrophage/dermal tissue
interfaces). The results are:
S sinh / cosh(7-)
-3/2+ -
-
sinh 
(B9)
_cos ( ) sinh(-)
cosh /3)8+ J / = + sinh ( ) + lhcosh ( 1)
- ~3/ sinh (,) +4 cosh(J8)
BJ= (B1O)
sinh
cosh ( 3)+ V=-h (+ V7)] sinsinh ( + /3 O cosh (N )
- sinh (f cosh (
3/2 
+
C = I (B 11)
8cosh + sinh () + - cosh )
csinh (J -  fi sinh (J i Of cosh (V-)
cosh ( ) + + sh /
- 68 
sisinh(h/3) n
e cosh P8+ J6 J + J, sinh (V16 + cosh (JB (B12)
Pd#p sinh (1=+
+3/2 +
+ /
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To obtain dimensional concentrations (as plotted in Figures 4.3 and 4.4), the concentrations in
Eqs. B6-B8 were each multiplied by Cuo.
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Appendix C: Modeling Intratumoral Blood Vessels for Melanoma Model
To probe the effects of including blood vessels in the intratumoral NO synthesis model, a
Krogh-type approach was used to solve for an effective volumetric first-order rate constant for
total NO consumption in a vascularized tumor (k,'). This approximation is only appropriate for
considering bulk or average properties of tissue on larger length scales, as is the case with the
intraumoral NO synthesis model. Briefly, two concentric cylinders were used to represent a
single blood vessel (inner cylinder) surrounded by a unit cell of tumor tissue (outer cylinder).
The governing equation and boundary conditions for NO concentrations in an annulus of
(extravascular) melanoma tissue is thus:
- ar k 0NQ CN 0
r ar r DNO (C1)
Cuo (R,) = 0 (C2)
C (R ) = X (C3)
Where kc is the first-order rate constant for intracellular NO consumption (as previously
defined), RI is the radius of a capillary (approximated as 5 im [Tufto and Rofstad, 1999], and R2
is the distance between blood vessels (70 jim [Dadras et al, 2003; Kiss et al, 2007]). The
boundary conditions are such that NO is assumed to be consumed instantaneously at the surface
of the blood vessel (the inner radius of the annulus) due to the fast reaction with oxyhemoglobin
(Eq. C2), and the NO concentration at the outer boundary of the annulus is an arbitrary constant
(Eq. C3).
The solution to Eq. Cl is:
C (r) = A,I o (mr)+ A2K, (mr) (C4)
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(C5)
S(m loI (mR, ) Ko (mR2)
Ko (mR2 )
Ko (mR,)
XI, (mR,) (C6)
(mIR2 )- 1 (mR) K, (mR2)
Ko ( mR
Where m = (ke / DNO )1/2, Io and I,, Ko, and K1 are the modified Bessel functions of the first and
second kind, respectively. With an expression for NO concentrations in the annulus, the average
volumetric NO consumption rate for a cylinder of vascularized tumor tissue is given by:
ac
(2R 2L) D ac
ar
S(R2 R12)L (C7)
Where the left hand side of Eq. C7 represents the total flux of NO into the cylinder at R2 and
CNO is the average extravascular NO concentration (i.e. A16 averaged over the entire annulus
volume). Thus, the effective first-order rate constant for total NO consumption, kc , is given by:
k.R 2 [Ko (mR,2) I, (mR2) + I0 (mR, ) K, (mR2 )]
Ko (mR )(R 2I, (mR2 ) - R,I, (mR,1 ))+ I (mR, )(R 2K, (mR 2 )- R,K, (mR,))
(C8)
From Eq. C8, it is seen that embedded in the effective rate for NO consumption for vascularized
tumor tissue is kc, the intracellular NO consumption rate; the additional terms capture the
additional consumption from having NO sinks/blood vessels distributed homogeneously
throughout the region. Note that the arbitrary constant, X, which appears in Eq. C4-C6 is
canceled out in solving for kc.
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Ko (mR) Io
XIo 
( mRl )
k ' =
,
Plugging in values of R1, R2, m, and kc (for A375 cells listed in Table 3.2) into Eq. C8, the value
for k,' in the melanoma is 7.2 s- ', which is only 1.4% larger than kc (7.1 s-'). As such, using k,'
instead of k, has a negligible effect on the calculated intratumoral NO concentration (kg/lk).
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Appendix D: Experimental Data
Summary of Experimental Data Plots
Figures Description Corresponding Chapter
D.1-D.3 02 consumption by unactivated RAW264.7 cells
D.4-D.6 02 consumption by unactivatd BMDM
D.7-D.9 02 consumption by unactivatd HCT116 cells
D. 10-D.11 Nitrite/nitrate accumulation for IFNy/LPS-treated
macrophages
D.12-D.16 NO and 02 measurements for IFNy/LPS-activated
BMDM
D. 17-D.21 NO and 02 measurements for IFNy/LPS-activated
RAW264.7 cells
D.21-D.26 NO and 02 measurements for capsaicin/resveratrol-
activated HCT116 cells
D.27-D.29 Superoxide production by IFNy/LPS-activated
BMDM
D.30-D.32 Superoxide production by IFNy/LPS-activated
RAW264.7 cells
D.33-D.34 NO consumption in DMEM cell culture media
D.35-D.39 NO consumption in A375 melanoma cells
Chapter 3 (Figure 3.3)
Chapter 3 (Figure 3.4)
Chapter 3 (Figure 3.5)
Chapter 3
Chapter 3 (Figure 3.6)
Chapter 3 (Figure 3.7)
Chapter 3 (Figure 3.8)
Chapter 3 (Figure 3.11)
Chapter 3 (Figure 3.12)
Chapter 4 (Figure 4.2)
Chapter 4 (Figure 4.2)
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Figure D.1. Time dependence of 02 concentrations for 12 x 106 unactivated RAW246.7 cells
(Experiment 2).
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Figure D.2. Time dependence of 02 concentrations for 9 x 106 unactivated RAW246.7 cells
(Experiment 3).
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Figure D.3. Time dependene of 02 concentrations for 10 x 106 unactivated RAW246.7 cells
(Experiment 4).
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Figure D.4. Time dependence of 02 concentrations for 4 x 106 unactivated primary bone
marrow-derived macrophages (Experiment 2).
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Figure D.5. Time dependence of 02 concentrations for 5 x 106 unactivated primary bone
marrow-derived macrophages (Experiment 3).
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Figure D.6. Time dependence of 02 concentrations for 4 x 106 unactivated primary bone
marrow-derived macrophages (Experiment 4).
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Figre D.7. Time dependence of 02 concentrations for 4 x 106 unactivated HCT116 colonic
epithelial cells (Experiment 2),
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Figure D.8. Time dependence of 02 concentrations for 6 X 106 unactivated HCT116 colonic
epithelial cells (Experiment 3).
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Figure D.9. Time dependence of 02 concentrations for 4 x 106 unactivated HCT116 colonic
epithelial cells (Experiment 4).
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Figure D.10. Nitrite accumulation data as a function of time for unactivated RAW264.7 cells
and primary BMDM and macrophages activated with IFNy and LPS (Experiment 1).
153
0.1
0.08
0
0oE
I,-
.m
0.06
0.04
0.02
-D
U
0 I.,.. I,,,
i _ _I.... I ...... I. .
o-)
CD
o
o
E
1-
0.25
0.2
0.15
0.1 F
0.05
U _
0-
0
05 o
0 1,0, , I , l, , I . I, 1 ,__ I  ,,. 0
0 10 20 30 40 50 60 70 80
time (h)
Figure D.11. Nitrite accumulation data as a function of time for unactivated RAW264.7 cells
and primary BMDM and macrophages activated with IFNy and LPS (Experiment 2).
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Figure D.12. Plot of NO and 02 concentrations as a function of time for 7 x 106 primary bone
marrow-derived macrophages activated with IFNy and LPS. (Experiment 2)
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Figure D.13. Plot of NO and 02 concentrations as a function of time for 8 x 106 bone marrow-
derived macrophages activated with IFNy and LPS. (Experiment 3)
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Figure D.14. Plot of NO and 02 concentrations as a function of time for 7 x 106 bone marrow-
derived macrophages activated with IFNy and LPS. (Experiment 4)
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Figure D.15. Plot of NO and 02 concentrations as a function of time for 5 x 106 bone marrow-
derived macrophages activated with IFNy and LPS. (Experiment 5)
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Figure D.16. Plot of NO and 02 concentrations as a function of time for 6 x 106 bone marrow-
derived macrophages activated with IFNy and LPS. (Experiment 6)
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Figure D.17. Plot of NO and 02 concentrations as a function of time for 6 X 106 RAW264.7
cells activated with IFNy and LPS. (Experiment 2)
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Figure D.18. Plot of NO and 02 concentrations as a function of time for 8 X 106 RAW264.7
cells activated with IFNy and LPS. (Experiment 3)
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Figure D.19. Plot of NO and 02 concentrations as a function of time for 8 x 106 RAW264.7
cells activated with IFNy and LPS. (Experiment 4)
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Figure D.20. Plot of NO and 02 concentrations as a function of time for 8 x 106 RAW264.7
cells activated with IFNy and LPS. (Experiment 5)
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Figure D.21. Plot of NO and 02 concentrations as a function of time for 8 x 106 RAW264.7
cells activated with IFNy and LPS. (Experiment 6)
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Figure D.22. Plot of NO and 02 concentrations as a function of time for 7 X 106 HCT116
colonic epithelial cells activated with capsaicin and resveratrol. (Experiment 2)
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Figure D.23. Plot of NO and 02 concentrations as a function of time for 7 X 106 HCT116
colonic epithelial cells activated with capsaicin and resveratrol. (Experiment 3)
166
_ _
0.3
0.25
0.2
0.15
0.1
0.05
0
0 200 400 600 800 1000
250
245
0
240 o
235
230
225
1200
time (s)
Figure D.24. Plot of NO and 02 concentrations as a function of time for 7 X 10 HCT116
colonic epithelial cells activated with capsaicin and resveratrol. (Experiment 4)
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Figure D.25. Plot of NO and 02 concentrations as a function of time for 7 x 106 HCT116
colonic epithelial cells activated with capsaicin and resveratrol. (Experiment 5)
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Figure D.26. Plot of NO and 02 concentrations as a function of time for 7 x 106 HCT116
colonic epithelial cells activated with capsaicin and resveratrol. (Experiment 6)
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Figure D.27. Ferrocytochrome c concentrations as function of time for 5 x 105 primary bone
marrow-derived macrophages. (Experiment 2)
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Figure D.28. Ferrocytochrome c concentrations as function of time for 5 x 105 primary bone
marrow-derived macrophages. (Experiment 3)
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Figure D.29. Ferrocytochrome c concentrations as function of time for 5 x 105 primary bone
marrow-derived macrophages. (Experiment 4)
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Figure D.30. Ferrocytochrome c concentrations as function of time for 5 x 105 RAW 264.7
cells. (Experiment 2)
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Figure D.31. Ferrocytochrome c concentrations as function of time for 5 x 105 RAW 264.7
cells. (Experiment 3)
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Figure D.32. Ferrocytochrome c concentrations as function of time for 5 x 105 RAW 264.7
cells. (Experiment 4)
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Figure D.33. Plots of NO concentrations as a function of time for cell culture media (DMEM
and HEPES in the dark at 37 'C) following an injection of saturated NO
(Experiment2)
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Figure D.34. Plots of NO concentrations as a function of time for cell culture media (DMEM
and HEPES in the dark at 37 oC) following an injection of saturated NO solutions. (Experiment
3)
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Figure D.35. Plots of NO and 02 concentrations as a function of time for 5 x 106 A375
melanoma cells. (Experiment 2)
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Figure D.36. Plots of NO concentrations as a function of time for 3.5 x 106 A375 melanoma
cells. (Experiment 3)
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Figure D.37. Plots of NO and 02 concentrations as a function of time for 4x 106 A375
melanoma cells. (Experiment 4)
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Figure D.38. Plots of NO and 02 concentrations as a function of time for 5X 106 A375
melanoma cells. (Experiment 5)
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Figure D.39. Plots of NO and 02 concentrations as a function of time for 5 x 106 A375
melanoma cells. (Experiment 6)
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